,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-1799339,R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,39/230,108/8183,8.75339635734181e-34,6.15363763921129e-31,5.1967532058324e-31,RPS21/RPL13/RPS27/RPS29/SEC61G/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/SSR4/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/SPCS1/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14/RPN1/SEC11C,39
R-HSA-156842,R-HSA-156842,Eukaryotic Translation Elongation,36/230,89/8183,2.57069385944923e-33,9.03598891596403e-31,7.63090177225981e-31,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/EEF2/EEF1A2/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,36
R-HSA-156902,R-HSA-156902,Peptide chain elongation,35/230,85/8183,9.9048567520429e-33,2.32103809889539e-30,1.96011902040428e-30,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/EEF2/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,35
R-HSA-192823,R-HSA-192823,Viral mRNA Translation,34/230,85/8183,2.74613295721655e-31,4.82632867230808e-29,4.07583944176351e-29,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
R-HSA-2408557,R-HSA-2408557,Selenocysteine synthesis,34/230,89/8183,1.78767605627493e-30,2.09456044593546e-28,1.7688584135773e-28,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
R-HSA-72764,R-HSA-72764,Eukaryotic Translation Termination,34/230,89/8183,1.78767605627493e-30,2.09456044593546e-28,1.7688584135773e-28,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
R-HSA-72689,R-HSA-72689,Formation of a pool of free 40S subunits,35/230,97/8183,2.460254012655e-30,2.47079795842352e-28,2.08659137313898e-28,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14/EIF3L,35
R-HSA-975956,R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),34/230,91/8183,4.37381025371195e-30,3.84348576044937e-28,3.2458276093336e-28,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
R-HSA-156827,R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,36/230,107/8183,6.27886277268785e-30,4.9044894768884e-28,4.14184632022918e-28,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/EIF4A2/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14/EIF3L,36
R-HSA-72706,R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,36/230,108/8183,9.19850404110083e-30,6.46654834089389e-28,5.46100660966408e-28,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/EIF4A2/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14/EIF3L,36
R-HSA-72613,R-HSA-72613,Eukaryotic Translation Initiation,36/230,115/8183,1.17842520281585e-28,6.90360764649619e-27,5.83010363498368e-27,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/EIF4A2/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14/EIF3L,36
R-HSA-72737,R-HSA-72737,Cap-dependent Translation Initiation,36/230,115/8183,1.17842520281585e-28,6.90360764649619e-27,5.83010363498368e-27,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/EIF4A2/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14/EIF3L,36
R-HSA-927802,R-HSA-927802,Nonsense-Mediated Decay (NMD),34/230,111/8183,9.89067075052959e-27,4.96652966973021e-25,4.19423932578849e-25,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
R-HSA-975957,R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),34/230,111/8183,9.89067075052959e-27,4.96652966973021e-25,4.19423932578849e-25,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
R-HSA-168255,R-HSA-168255,Influenza Life Cycle,37/230,139/8183,1.36025841431656e-26,6.37507776843026e-25,5.38375961876869e-25,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/HSPA1A/CALR/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/HSPA1B/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,37
R-HSA-168254,R-HSA-168254,Influenza Infection,38/230,149/8183,1.49850396986806e-26,6.5840518176078e-25,5.56023841451044e-25,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/HSPA1A/CALR/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/HSPA1B/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/SLC25A6/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,38
R-HSA-2408522,R-HSA-2408522,Selenoamino acid metabolism,34/230,113/8183,1.93689202771719e-26,8.0096182087364e-25,6.76413067264705e-25,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
R-HSA-168273,R-HSA-168273,Influenza Viral RNA Transcription and Replication,34/230,129/8183,2.5535717561848e-24,9.97311635887731e-23,8.4223068449604e-23,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
R-HSA-376176,R-HSA-376176,Signaling by ROBO receptors,41/230,205/8183,3.49100539473024e-24,1.29167199605019e-22,1.09081830616502e-22,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RHOA/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/CDC42/RPLP0/RAC1/RPS5/RPL27/PFN2/RPS4Y1/PSMB8/RPS3/RPLP1/RBX1/RPL18A/RPL41/RPL27A/RPS13/PSMA6/RPS14,41
R-HSA-9010553,R-HSA-9010553,Regulation of expression of SLITs and ROBOs,37/230,162/8183,5.16071175030602e-24,1.81399018023257e-22,1.53191654061716e-22,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/PSMB8/RPS3/RPLP1/RBX1/RPL18A/RPL41/RPL27A/RPS13/PSMA6/RPS14,37
R-HSA-72766,R-HSA-72766,Translation,45/230,287/8183,6.24477157644184e-22,2.09051162773267e-20,1.76543918251288e-20,RPS21/RPL13/RPS27/RPS29/SEC61G/RPS2/RPL37A/RPS28/RPL38/EIF4A2/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/EEF2/SSR4/EEF1A2/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/MRPS24/SPCS1/RPS5/RPL27/MRPL33/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14/EIF3L/RPN1/SEC11C,45
R-HSA-5663205,R-HSA-5663205,Infectious disease,48/230,362/8183,3.47552940475419e-20,1.11058962342827e-18,9.37894059464767e-19,B2M/RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/HSPA1A/CALR/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/EEF2/CD9/RPS18/RPL36/HSPA1B/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/SLC25A6/RAC1/PPIA/RPS5/RPL27/RPS4Y1/PSMB8/RPS3/RPLP1/RBX1/RPL18A/RPL41/RPL27A/RPS13/PSMA6/SYT1/RPS14/RANBP1,48
R-HSA-6791226,R-HSA-6791226,Major pathway of rRNA processing in the nucleolus and cytosol,34/230,179/8183,2.22326181388978e-19,6.79544806593269e-18,5.73876275988027e-18,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
R-HSA-8868773,R-HSA-8868773,rRNA processing in the nucleus and cytosol,34/230,189/8183,1.34166861695505e-18,3.92997099049749e-17,3.31886447352038e-17,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
R-HSA-72312,R-HSA-72312,rRNA processing,34/230,198/8183,6.1244846981485e-18,1.72220509711936e-16,1.45440394516032e-16,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/RPS5/RPL27/RPS4Y1/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/RPS14,34
R-HSA-422475,R-HSA-422475,Axon guidance,50/230,498/8183,7.96009390407708e-16,2.1522869286793e-14,1.81760848659898e-14,RPS21/TUBB2B/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RHOA/RPL3/CD24/RPL15/RPL37/RPL24/RPL29/TUBA1A/RPL14/TUBB2A/TUBB3/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/CDC42/RPLP0/RAC1/RHOB/RPS5/RPL27/PFN2/RPS4Y1/PSMB8/RPS3/RPLP1/RBX1/RPL18A/RPL41/RPL27A/RPS13/PSMA6/ALCAM/RPS14/DPYSL3/TUBB4B,50
R-HSA-71291,R-HSA-71291,Metabolism of amino acids and derivatives,38/230,320/8183,1.91401111534295e-14,4.9835178299485e-13,4.20858584426287e-13,RPS21/RPL13/RPS27/RPS29/RPS2/RPL37A/RPS28/RPL38/RPL3/RPL15/RPL37/RPL24/RPL29/RPL14/RPS18/RPL36/RPL39/RPL32/RPSA/RPL34/RPS19/RPL36A/RPL35A/RPLP0/ODC1/RPS5/RPL27/RPS4Y1/PSMB8/RPS3/RPLP1/RPL18A/RPL41/RPL27A/RPS13/PSMA6/RPS14/PCBD1,38
R-HSA-72649,R-HSA-72649,Translation initiation complex formation,15/230,57/8183,2.64805337054563e-11,6.41924661894336e-10,5.42106025766872e-10,RPS21/RPS27/RPS29/RPS2/RPS28/EIF4A2/RPS18/RPSA/RPS19/RPS5/RPS4Y1/RPS3/RPS13/RPS14/EIF3L,15
R-HSA-72702,R-HSA-72702,Ribosomal scanning and start codon recognition,15/230,57/8183,2.64805337054563e-11,6.41924661894336e-10,5.42106025766872e-10,RPS21/RPS27/RPS29/RPS2/RPS28/EIF4A2/RPS18/RPSA/RPS19/RPS5/RPS4Y1/RPS3/RPS13/RPS14/EIF3L,15
R-HSA-72662,R-HSA-72662,Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S,15/230,58/8183,3.48361688590121e-11,8.16327556929517e-10,6.89389446894135e-10,RPS21/RPS27/RPS29/RPS2/RPS28/EIF4A2/RPS18/RPSA/RPS19/RPS5/RPS4Y1/RPS3/RPS13/RPS14/EIF3L,15
R-HSA-72695,R-HSA-72695,Formation of the ternary complex, and subsequently, the 43S complex,14/230,50/8183,4.94789274148034e-11,1.12205438621312e-09,9.47576063224079e-10,RPS21/RPS27/RPS29/RPS2/RPS28/RPS18/RPSA/RPS19/RPS5/RPS4Y1/RPS3/RPS13/RPS14/EIF3L,14
R-HSA-6798695,R-HSA-6798695,Neutrophil degranulation,28/230,379/8183,2.35727943266389e-06,5.17864825363347e-05,4.37337368428431e-05,B2M/HLA-C/HLA-B/FABP5/RHOA/HSPA1A/EEF2/NPC2/VAMP8/CD63/PSAP/MIF/HSPA1B/DPP7/GRN/MME/HSPA6/RAC1/PPIA/FTH1/APRT/DSP/CSTB/SVIP/ALDOA/GGH/CD47/TUBB4B,28
R-HSA-8953897,R-HSA-8953897,Cellular responses to external stimuli,32/230,470/8183,2.4949661629213e-06,5.31503397737477e-05,4.4885515658297e-05,TUBB2B/HSPA1A/TUBA1A/CA9/TUBB2A/TUBB3/TERF2IP/HSPA1B/FOS/GABARAP/GABARAPL2/TOMM7/HIST1H1C/HIST1H2AC/HSBP1/HSPA6/HIST1H4C/SNCB/PSMB8/HSPA5/H2AFV/WIPI2/RBX1/MAP1LC3B/PSMA6/CDKN1A/JUN/MT2A/CAMK2B/DNAJB1/TUBB4B/VEGFA,32
R-HSA-389977,R-HSA-389977,Post-chaperonin tubulin folding pathway,6/230,16/8183,2.92184841413261e-06,6.04135127980948e-05,5.10192726182908e-05,TUBB2B/TUBA1A/TUBB2A/TUBB3/TBCD/TUBB4B,6
R-HSA-983170,R-HSA-983170,Antigen Presentation: Folding, assembly and peptide loading of class I MHC,7/230,25/8183,3.94737050818527e-06,7.92857562072641e-05,6.69569012516238e-05,B2M/HLA-A/HLA-C/HLA-B/PDIA3/CALR/HSPA5,7
R-HSA-76002,R-HSA-76002,Platelet activation, signaling and aggregation,19/230,207/8183,5.19126319342986e-06,0.000100195305080555,8.46150364085247e-05,TIMP1/TAGLN2/RHOA/GNB2/LGALS3BP/CD9/CD63/PSAP/GNG2/CDC42/RAC1/PPIA/RHOB/HGF/HSPA5/ALDOA/MANF/CHID1/VEGFA,19
R-HSA-5626467,R-HSA-5626467,RHO GTPases activate IQGAPs,7/230,26/8183,5.27343710950291e-06,0.000100195305080555,8.46150364085247e-05,TUBB2B/TUBA1A/TUBB2A/TUBB3/CDC42/RAC1/TUBB4B,7
R-HSA-114608,R-HSA-114608,Platelet degranulation ,13/230,103/8183,5.53958077268211e-06,0.000102482244294619,8.65463588862247e-05,TIMP1/TAGLN2/LGALS3BP/CD9/CD63/PSAP/PPIA/HGF/HSPA5/ALDOA/MANF/CHID1/VEGFA,13
R-HSA-76005,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,13/230,106/8183,7.64312554697325e-06,0.000137772237423646,0.000116348793751496,TIMP1/TAGLN2/LGALS3BP/CD9/CD63/PSAP/PPIA/HGF/HSPA5/ALDOA/MANF/CHID1/VEGFA,13
R-HSA-190840,R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,5/230,12/8183,1.13223363861644e-05,0.000194136645840818,0.000163948593627643,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-190872,R-HSA-190872,Transport of connexons to the plasma membrane,5/230,12/8183,1.13223363861644e-05,0.000194136645840818,0.000163948593627643,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-3371497,R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR),8/230,46/8183,3.57657729964053e-05,0.000598650914677927,0.000505561302505579,TUBB2B/HSPA1A/TUBA1A/TUBB2A/TUBB3/HSPA1B/DNAJB1/TUBB4B,8
R-HSA-2262752,R-HSA-2262752,Cellular responses to stress,25/230,378/8183,5.56773073973299e-05,0.00091025923489123,0.000768714843870112,TUBB2B/HSPA1A/TUBA1A/CA9/TUBB2A/TUBB3/TERF2IP/HSPA1B/FOS/HIST1H1C/HIST1H2AC/HSBP1/HSPA6/HIST1H4C/PSMB8/HSPA5/H2AFV/RBX1/PSMA6/CDKN1A/JUN/CAMK2B/DNAJB1/TUBB4B/VEGFA,25
R-HSA-1236974,R-HSA-1236974,ER-Phagosome pathway,10/230,78/8183,5.9621875277015e-05,0.000952594961812307,0.000804467408043934,B2M/HLA-A/HLA-C/HLA-B/SEC61G/PDIA3/CALR/VAMP8/PSMB8/PSMA6,10
R-HSA-1445148,R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,9/230,64/8183,6.70754389946311e-05,0.00104786741362724,0.000884925089894081,TUBB2B/TUBA1A/TUBB2A/TUBB3/RAB13/YWHAH/RAC1/YWHAG/TUBB4B,9
R-HSA-109582,R-HSA-109582,Hemostasis,28/230,461/8183,8.84463322453749e-05,0.00135169068627171,0.00114150415071834,TUBB2B/TIMP1/TAGLN2/BSG/RHOA/GNB2/TUBA1A/LGALS3BP/TUBB2A/EPCAM/TUBB3/CD9/CD63/PSAP/MIF/GNG2/CDC42/RAC1/PPIA/RHOB/HGF/HSPA5/ALDOA/MANF/CHID1/CD47/TUBB4B/VEGFA,28
R-HSA-190861,R-HSA-190861,Gap junction assembly,5/230,19/8183,0.000141455377079054,0.00207173187680365,0.00174957966387251,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-389960,R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,5/230,19/8183,0.000141455377079054,0.00207173187680365,0.00174957966387251,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-1236977,R-HSA-1236977,Endosomal/Vacuolar pathway,4/230,11/8183,0.000171761414677636,0.00246425050037506,0.0020810620381995,B2M/HLA-A/HLA-C/HLA-B,4
R-HSA-1236975,R-HSA-1236975,Antigen processing-Cross presentation,10/230,89/8183,0.0001839479706095,0.00258630846676957,0.00218414011418438,B2M/HLA-A/HLA-C/HLA-B/SEC61G/PDIA3/CALR/VAMP8/PSMB8/PSMA6,10
R-HSA-9609736,R-HSA-9609736,Assembly and cell surface presentation of NMDA receptors,6/230,31/8183,0.000188581546899299,0.00259946720529818,0.00219525268217141,TUBB2B/TUBA1A/TUBB2A/TUBB3/CAMK2B/TUBB4B,6
R-HSA-9619483,R-HSA-9619483,Activation of AMPK downstream of NMDARs,5/230,22/8183,0.000299008003232751,0.00400494306676936,0.0033821784677067,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-5663220,R-HSA-5663220,RHO GTPases Activate Formins,12/230,131/8183,0.000301937386257149,0.00400494306676936,0.0033821784677067,TUBB2B/RPS27/RHOA/TUBA1A/TUBB2A/TUBB3/CDC42/RAC1/RHOB/PFN2/MAD1L1/TUBB4B,12
R-HSA-3371571,R-HSA-3371571,HSF1-dependent transactivation,5/230,24/8183,0.000460958524820476,0.00589188805361444,0.00497570541624399,HSPA1A/HSPA1B/HSBP1/CAMK2B/DNAJB1,5
R-HSA-389957,R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC,5/230,24/8183,0.000460958524820476,0.00589188805361444,0.00497570541624399,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-3371568,R-HSA-3371568,Attenuation phase,4/230,14/8183,0.0004874433320378,0.00611915468611738,0.00516763231709247,HSPA1A/HSPA1B/HSBP1/DNAJB1,4
R-HSA-8852276,R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,8/230,69/8183,0.000657662577346566,0.00811117178727432,0.00684989277236313,TUBB2B/TUBA1A/TUBB2A/TUBB3/PSMB8/PSMA6/CDKN1A/TUBB4B,8
R-HSA-389958,R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,5/230,26/8183,0.000681424431400059,0.00825933405645245,0.00697501595843255,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-391251,R-HSA-391251,Protein folding,9/230,88/8183,0.000775963624021265,0.00924580385910084,0.00780809070380007,TUBB2B/RGS7/GNB2/TUBA1A/TUBB2A/TUBB3/GNG2/TBCD/TUBB4B,9
R-HSA-6785807,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,8/230,72/8183,0.000875860989328216,0.0102621712582956,0.00866641399966867,TIMP1/HSP90B1/FSCN1/FOS/HGF/CDKN1A/JUNB/VEGFA,8
R-HSA-163200,R-HSA-163200,Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.,10/230,110/8183,0.00101493517603601,0.0116967119467756,0.00987788506098892,NDUFB1/COX4I1/ATP5F1E/NDUFB4/ATP5ME/NDUFAF3/NDUFA3/NDUFA6/UQCR10/NDUFS5,10
R-HSA-190828,R-HSA-190828,Gap junction trafficking,5/230,29/8183,0.00114858277060254,0.0128179366159978,0.0108247604273756,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-5625740,R-HSA-5625740,RHO GTPases activate PKNs,8/230,75/8183,0.00114869133258587,0.0128179366159978,0.0108247604273756,RHOA/HIST1H2AC/YWHAH/RAC1/HIST1H4C/RHOB/H2AFV/YWHAG,8
R-HSA-195258,R-HSA-195258,RHO GTPase Effectors,18/230,291/8183,0.00137445037885533,0.015097478380239,0.0127498357512238,TUBB2B/RPS27/RHOA/TUBA1A/TUBB2A/TUBB3/HIST1H2AC/YWHAH/CDC42/RAC1/BRK1/HIST1H4C/RHOB/PFN2/MAD1L1/H2AFV/YWHAG/TUBB4B,18
R-HSA-157858,R-HSA-157858,Gap junction trafficking and regulation,5/230,31/8183,0.00156996259519464,0.0169797492987974,0.0143394154443688,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-1428517,R-HSA-1428517,The citric acid (TCA) cycle and respiratory electron transport,12/230,158/8183,0.00160989343531783,0.0171478043186126,0.014481338078457,BSG/NDUFB1/COX4I1/ATP5F1E/NDUFB4/ATP5ME/NDUFAF3/MDH2/NDUFA3/NDUFA6/UQCR10/NDUFS5,12
R-HSA-8955332,R-HSA-8955332,Carboxyterminal post-translational modifications of tubulin,5/230,32/8183,0.00181871335778498,0.0190829177689976,0.0161155433431379,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-390466,R-HSA-390466,Chaperonin-mediated protein folding,8/230,82/8183,0.0020514596570015,0.0212084726304714,0.0179105765719636,TUBB2B/RGS7/GNB2/TUBA1A/TUBB2A/TUBB3/GNG2/TUBB4B,8
R-HSA-381183,R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,3/230,10/8183,0.00227205480322054,0.0231486163284643,0.0195490298858335,HSP90B1/CALR/HSPA5,3
R-HSA-6799198,R-HSA-6799198,Complex I biogenesis,6/230,49/8183,0.00235014794547939,0.0236022000810287,0.0199320818233139,NDUFB1/NDUFB4/NDUFAF3/NDUFA3/NDUFA6/NDUFS5,6
R-HSA-438064,R-HSA-438064,Post NMDA receptor activation events,7/230,68/8183,0.00285485416785373,0.0282670771831151,0.0238715752508451,TUBB2B/TUBA1A/TUBB2A/TUBB3/RAC1/CAMK2B/TUBB4B,7
R-HSA-5625970,R-HSA-5625970,RHO GTPases activate KTN1,3/230,11/8183,0.00305966482392412,0.0298742273780369,0.025228815214813,RHOA/CDC42/RAC1,3
R-HSA-380320,R-HSA-380320,Recruitment of NuMA to mitotic centrosomes,8/230,88/8183,0.00320452783738354,0.0308600420504196,0.0260613367020089,TUBB2B/MZT2B/TUBA1A/TUBB2A/TUBB3/MZT2A/YWHAG/TUBB4B,8
R-HSA-611105,R-HSA-611105,Respiratory electron transport,8/230,90/8183,0.00368405794238139,0.0349985504526232,0.0295563112304851,NDUFB1/COX4I1/NDUFB4/NDUFAF3/NDUFA3/NDUFA6/UQCR10/NDUFS5,8
R-HSA-381033,R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,3/230,12/8183,0.00399555944729105,0.0369589248874422,0.031211849422052,HSP90B1/CALR/HSPA5,3
R-HSA-381771,R-HSA-381771,Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1),3/230,12/8183,0.00399555944729105,0.0369589248874422,0.031211849422052,GRP/SPCS1/SEC11C,3
R-HSA-397795,R-HSA-397795,G-protein beta:gamma signalling,4/230,24/8183,0.00414980382037784,0.0378871699444885,0.0319957533109105,RHOA/GNB2/GNG2/CDC42,4
R-HSA-5358351,R-HSA-5358351,Signaling by Hedgehog,10/230,134/8183,0.00439903880050415,0.0396477471378771,0.033482562530153,TUBB2B/EVC2/TUBA1A/TUBB2A/TUBB3/OS9/PSMB8/RBX1/PSMA6/TUBB4B,10
R-HSA-437239,R-HSA-437239,Recycling pathway of L1,5/230,40/8183,0.00495385748344094,0.0440830608969491,0.0372281894824875,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-3000480,R-HSA-3000480,Scavenging by Class A Receptors,3/230,13/8183,0.00508743268993359,0.0441538911237446,0.0372880056806049,HSP90B1/CALR/FTH1,3
R-HSA-400508,R-HSA-400508,Incretin synthesis, secretion, and inactivation,3/230,13/8183,0.00508743268993359,0.0441538911237446,0.0372880056806049,GRP/SPCS1/SEC11C,3
R-HSA-442755,R-HSA-442755,Activation of NMDA receptors and postsynaptic events,7/230,76/8183,0.00532979564812003,0.0456932480564436,0.0385879941661065,TUBB2B/TUBA1A/TUBB2A/TUBB3/RAC1/CAMK2B/TUBB4B,7
R-HSA-69275,R-HSA-69275,G2/M Transition,12/230,187/8183,0.00638377578862823,0.0540698118000681,0.0456620107138405,TUBB2B/MZT2B/TUBA1A/TUBB2A/TUBB3/MZT2A/PSMB8/RBX1/PSMA6/CDKN1A/YWHAG/TUBB4B,12
R-HSA-6811436,R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,5/230,43/8183,0.00677066056050059,0.056663980643237,0.0478527889238387,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-453274,R-HSA-453274,Mitotic G2-G2/M phases,12/230,189/8183,0.00693314865482155,0.0569476560313199,0.0480923530757872,TUBB2B/MZT2B/TUBA1A/TUBB2A/TUBB3/MZT2A/PSMB8/RBX1/PSMA6/CDKN1A/YWHAG/TUBB4B,12
R-HSA-373760,R-HSA-373760,L1CAM interactions,8/230,100/8183,0.00696656958562378,0.0569476560313199,0.0480923530757872,TUBB2B/CD24/TUBA1A/TUBB2A/TUBB3/RAC1/ALCAM/TUBB4B,8
R-HSA-114604,R-HSA-114604,GPVI-mediated activation cascade,4/230,28/8183,0.00732493388374243,0.0591888335663325,0.0499850297692769,RHOA/CDC42/RAC1/RHOB,4
R-HSA-5610787,R-HSA-5610787,Hedgehog 'off' state,8/230,102/8183,0.00782793880385122,0.062534556580766,0.0528104962365082,TUBB2B/TUBA1A/TUBB2A/TUBB3/PSMB8/RBX1/PSMA6/TUBB4B,8
R-HSA-2559586,R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,6/230,63/8183,0.00825067974799262,0.0651710995824586,0.0550370594662074,TERF2IP/HIST1H1C/HIST1H2AC/HIST1H4C/H2AFV/CDKN1A,6
R-HSA-8964616,R-HSA-8964616,G beta:gamma signalling through CDC42,3/230,16/8183,0.00936118548016223,0.0731212599172672,0.061750977904228,GNB2/GNG2/CDC42,3
R-HSA-110328,R-HSA-110328,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,5/230,47/8183,0.00985658636857201,0.0745073141624314,0.0629215021151626,TERF2IP/HIST1H2AC/HIST1H4C/H2AFV/NTHL1,5
R-HSA-110329,R-HSA-110329,Cleavage of the damaged pyrimidine ,5/230,47/8183,0.00985658636857201,0.0745073141624314,0.0629215021151626,TERF2IP/HIST1H2AC/HIST1H4C/H2AFV/NTHL1,5
R-HSA-73928,R-HSA-73928,Depyrimidination,5/230,47/8183,0.00985658636857201,0.0745073141624314,0.0629215021151626,TERF2IP/HIST1H2AC/HIST1H4C/H2AFV/NTHL1,5
R-HSA-3371556,R-HSA-3371556,Cellular response to heat stress,7/230,87/8183,0.0109991002188761,0.0822592282326586,0.0694680013823754,HSPA1A/HSPA1B/HSBP1/HSPA6/HSPA5/CAMK2B/DNAJB1,7
R-HSA-73929,R-HSA-73929,Base-Excision Repair, AP Site Formation,5/230,49/8183,0.0117125857805013,0.0862214343366074,0.0728140884417857,TERF2IP/HIST1H2AC/HIST1H4C/H2AFV/NTHL1,5
R-HSA-8950505,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,4/230,32/8183,0.0117888703453505,0.0862214343366074,0.0728140884417857,MIF/CDC42/RPLP0/PPIA,4
R-HSA-112314,R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,10/230,155/8183,0.0118968408686357,0.0862214343366074,0.0728140884417857,TUBB2B/GNB2/TUBA1A/TUBB2A/TUBB3/GNG2/RAC1/GRIK2/CAMK2B/TUBB4B,10
R-HSA-5620924,R-HSA-5620924,Intraflagellar transport,5/230,50/8183,0.0127240810245686,0.0903538278815323,0.0763038989671097,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-983189,R-HSA-983189,Kinesins,5/230,50/8183,0.0127240810245686,0.0903538278815323,0.0763038989671097,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-112315,R-HSA-112315,Transmission across Chemical Synapses,12/230,208/8183,0.0142167825440077,0.0999439812843739,0.084402793208635,TUBB2B/GNB2/TUBA1A/TUBB2A/TUBB3/GNG2/RAC1/GRIK2/CACNA2D1/SYT1/CAMK2B/TUBB4B,12
R-HSA-877300,R-HSA-877300,Interferon gamma signaling,6/230,71/8183,0.0144603671795402,0.100649882447691,0.0849989274545147,B2M/HLA-A/HLA-C/HLA-B/MT2A/CAMK2B,6
R-HSA-909733,R-HSA-909733,Interferon alpha/beta signaling,5/230,52/8183,0.0149210367477664,0.10283812582039,0.08684690119443,HLA-A/HLA-C/HLA-B/EGR1/PSMB8,5
R-HSA-392451,R-HSA-392451,G beta:gamma signalling through PI3Kgamma,3/230,19/8183,0.0152262757701584,0.103923027829333,0.0877631020374996,RHOA/GNB2/GNG2,3
R-HSA-5625900,R-HSA-5625900,RHO GTPases activate CIT,3/230,20/8183,0.0175486383268094,0.118622045612952,0.100176437412151,RHOA/RAC1/RHOB,3
R-HSA-9609523,R-HSA-9609523,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,3/230,21/8183,0.0200572842834405,0.134288293821511,0.11340659985825,SEC61G/CYB5A/SERP1,3
R-HSA-171306,R-HSA-171306,Packaging Of Telomere Ends,4/230,38/8183,0.0212420315450053,0.139246231528671,0.117593583262964,TERF2IP/HIST1H2AC/HIST1H4C/H2AFV,4
R-HSA-9020591,R-HSA-9020591,Interleukin-12 signaling,4/230,38/8183,0.0212420315450053,0.139246231528671,0.117593583262964,MIF/CDC42/RPLP0/PPIA,4
R-HSA-162909,R-HSA-162909,Host Interactions of HIV factors,8/230,122/8183,0.0213920241893264,0.139246231528671,0.117593583262964,B2M/SLC25A6/RAC1/PPIA/PSMB8/RBX1/PSMA6/RANBP1,8
R-HSA-73884,R-HSA-73884,Base Excision Repair,6/230,78/8183,0.0220823655745787,0.142421128430539,0.120274786905479,TERF2IP/HIST1H2AC/HIST1H4C/BPHL/H2AFV/NTHL1,6
R-HSA-5687128,R-HSA-5687128,MAPK6/MAPK4 signaling,6/230,81/8183,0.0260497981907308,0.166481892073488,0.140594126120308,CDC42/RAC1/PSMB8/PSMA6/JUN/DNAJB1,6
R-HSA-2980736,R-HSA-2980736,Peptide hormone metabolism,5/230,61/8183,0.0279176642998538,0.176811873899074,0.149317806212589,CPB1/GRP/MME/SPCS1/SEC11C,5
R-HSA-400685,R-HSA-400685,Sema4D in semaphorin signaling,3/230,24/8183,0.0287049619740649,0.180174895247925,0.15215788114072,RHOA/RAC1/RHOB,3
R-HSA-110330,R-HSA-110330,Recognition and association of DNA glycosylase with site containing an affected purine,4/230,42/8183,0.0295435076872958,0.180210862878679,0.152188255841245,TERF2IP/HIST1H2AC/HIST1H4C/H2AFV,4
R-HSA-110331,R-HSA-110331,Cleavage of the damaged purine,4/230,42/8183,0.0295435076872958,0.180210862878679,0.152188255841245,TERF2IP/HIST1H2AC/HIST1H4C/H2AFV,4
R-HSA-73927,R-HSA-73927,Depurination,4/230,42/8183,0.0295435076872958,0.180210862878679,0.152188255841245,TERF2IP/HIST1H2AC/HIST1H4C/H2AFV,4
R-HSA-111367,R-HSA-111367,SLBP independent Processing of Histone Pre-mRNAs,2/230,10/8183,0.0305051105015119,0.180210862878679,0.152188255841245,SNRPF/SNRPE,2
R-HSA-1234158,R-HSA-1234158,Regulation of gene expression by Hypoxia-inducible Factor,2/230,10/8183,0.0305051105015119,0.180210862878679,0.152188255841245,CA9/VEGFA,2
R-HSA-2022377,R-HSA-2022377,Metabolism of Angiotensinogen to Angiotensins,2/230,10/8183,0.0305051105015119,0.180210862878679,0.152188255841245,CPB1/MME,2
R-HSA-450341,R-HSA-450341,Activation of the AP-1 family of transcription factors,2/230,10/8183,0.0305051105015119,0.180210862878679,0.152188255841245,FOS/JUN,2
R-HSA-449147,R-HSA-449147,Signaling by Interleukins,16/230,342/8183,0.0313256553126041,0.183516130706339,0.154979557862357,TIMP1/HSP90B1/FSCN1/MIF/FOS/CDC42/RPLP0/PPIA/HGF/PSMB8/RBX1/PSMA6/CDKN1A/JUN/JUNB/VEGFA,16
R-HSA-901042,R-HSA-901042,Calnexin/calreticulin cycle,3/230,26/8183,0.0354001141410455,0.205671737530207,0.173689990217918,PDIA3/CALR/OS9,3
R-HSA-194315,R-HSA-194315,Signaling by Rho GTPases,18/230,405/8183,0.0360476954612494,0.207341928927397,0.175100468540918,TUBB2B/RPS27/RHOA/TUBA1A/TUBB2A/TUBB3/HIST1H2AC/YWHAH/CDC42/RAC1/BRK1/HIST1H4C/RHOB/PFN2/MAD1L1/H2AFV/YWHAG/TUBB4B,18
R-HSA-77588,R-HSA-77588,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,2/230,11/8183,0.0366040984298647,0.207341928927397,0.175100468540918,SNRPF/SNRPE,2
R-HSA-8875555,R-HSA-8875555,MET activates RAP1 and RAC1,2/230,11/8183,0.0366040984298647,0.207341928927397,0.175100468540918,RAC1/HGF,2
R-HSA-447115,R-HSA-447115,Interleukin-12 family signaling,4/230,45/8183,0.0368673415589255,0.207341928927397,0.175100468540918,MIF/CDC42/RPLP0/PPIA,4
R-HSA-913531,R-HSA-913531,Interferon Signaling,9/230,162/8183,0.0388168562179955,0.214321343406096,0.180994591122315,B2M/HLA-A/HLA-C/HLA-B/EIF4A2/EGR1/PSMB8/MT2A/CAMK2B,9
R-HSA-2559582,R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),6/230,89/8183,0.0388628918926282,0.214321343406096,0.180994591122315,FOS/HIST1H2AC/HIST1H4C/H2AFV/CDKN1A/JUN,6
R-HSA-70263,R-HSA-70263,Gluconeogenesis,3/230,27/8183,0.039022947305804,0.214321343406096,0.180994591122315,PGAM2/MDH2/ALDOA,3
R-HSA-3371453,R-HSA-3371453,Regulation of HSF1-mediated heat shock response,5/230,67/8183,0.039652217401661,0.21608921576254,0.182487561114131,HSPA1A/HSPA1B/HSPA6/HSPA5/DNAJB1,5
R-HSA-381426,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),6/230,91/8183,0.0425963596032568,0.22795069005372,0.192504588141496,TIMP1/HSP90B1/CHGB/PDIA6/IGFBP5/IGFBP2,6
R-HSA-418885,R-HSA-418885,DCC mediated attractive signaling,2/230,12/8183,0.0431258062263795,0.22795069005372,0.192504588141496,CDC42/RAC1,2
R-HSA-422085,R-HSA-422085,Synthesis, secretion, and deacylation of Ghrelin,2/230,12/8183,0.0431258062263795,0.22795069005372,0.192504588141496,SPCS1/SEC11C,2
R-HSA-5660526,R-HSA-5660526,Response to metal ions,2/230,12/8183,0.0431258062263795,0.22795069005372,0.192504588141496,SNCB/MT2A,2
R-HSA-68877,R-HSA-68877,Mitotic Prometaphase,10/230,193/8183,0.0454111482440251,0.238239083698132,0.201193146972743,TUBB2B/RPS27/MZT2B/TUBA1A/TUBB2A/TUBB3/MZT2A/MAD1L1/YWHAG/TUBB4B,10
R-HSA-451326,R-HSA-451326,Activation of kainate receptors upon glutamate binding,3/230,29/8183,0.0468090426304445,0.24196144830296,0.204336687643736,GNB2/GNG2/GRIK2,3
R-HSA-5339562,R-HSA-5339562,Uptake and actions of bacterial toxins,3/230,29/8183,0.0468090426304445,0.24196144830296,0.204336687643736,EEF2/CD9/SYT1,3
R-HSA-8848021,R-HSA-8848021,Signaling by PTK6,4/230,49/8183,0.0481174632815771,0.245120120919918,0.207004189861247,RHOA/RAC1/KHDRBS1/SFPQ,4
R-HSA-9006927,R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,4/230,49/8183,0.0481174632815771,0.245120120919918,0.207004189861247,RHOA/RAC1/KHDRBS1/SFPQ,4
R-HSA-1234174,R-HSA-1234174,Cellular response to hypoxia,5/230,71/8183,0.0489194791837233,0.247412905511924,0.208940448766527,CA9/PSMB8/RBX1/PSMA6/VEGFA,5
R-HSA-75035,R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,2/230,13/8183,0.0500418741420969,0.249707430495746,0.210878177434455,YWHAH/YWHAG,2
R-HSA-2500257,R-HSA-2500257,Resolution of Sister Chromatid Cohesion,7/230,119/8183,0.0500835671406831,0.249707430495746,0.210878177434455,TUBB2B/RPS27/TUBA1A/TUBB2A/TUBB3/MAD1L1/TUBB4B,7
R-HSA-2173782,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,3/230,30/8183,0.0509672872600917,0.250559461145766,0.211597718179549,HSP90B1/CALR/FTH1,3
R-HSA-2871796,R-HSA-2871796,FCERI mediated MAPK activation,3/230,30/8183,0.0509672872600917,0.250559461145766,0.211597718179549,FOS/RAC1/JUN,3
R-HSA-8849471,R-HSA-8849471,PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases,2/230,14/8183,0.0573251906254319,0.277667693301984,0.234490647633928,RHOA/RAC1,2
R-HSA-8964315,R-HSA-8964315,G beta:gamma signalling through BTK,2/230,14/8183,0.0573251906254319,0.277667693301984,0.234490647633928,GNB2/GNG2,2
R-HSA-72165,R-HSA-72165,mRNA Splicing - Minor Pathway,4/230,52/8183,0.0576664057213224,0.277667693301984,0.234490647633928,YBX1/SNRPF/SNRPE/TXNL4A,4
R-HSA-983231,R-HSA-983231,Factors involved in megakaryocyte development and platelet production,7/230,126/8183,0.0642537819984969,0.298429680231344,0.252024166580038,TUBB2B/TUBA1A/TUBB2A/TUBB3/CDC42/RAC1/TUBB4B,7
R-HSA-8864260,R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,3/230,33/8183,0.0644668567613309,0.298429680231344,0.252024166580038,CITED4/CDKN1A/VEGFA,3
R-HSA-450408,R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,4/230,54/8183,0.0645548495801655,0.298429680231344,0.252024166580038,HSPA1A/HSPA1B/PSMB8/PSMA6,4
R-HSA-111447,R-HSA-111447,Activation of BAD and translocation to mitochondria ,2/230,15/8183,0.0649498450574618,0.298429680231344,0.252024166580038,YWHAH/YWHAG,2
R-HSA-163210,R-HSA-163210,Formation of ATP by chemiosmotic coupling,2/230,15/8183,0.0649498450574618,0.298429680231344,0.252024166580038,ATP5F1E/ATP5ME,2
R-HSA-392851,R-HSA-392851,Prostacyclin signalling through prostacyclin receptor,2/230,15/8183,0.0649498450574618,0.298429680231344,0.252024166580038,GNB2/GNG2,2
R-HSA-430039,R-HSA-430039,mRNA decay by 5' to 3' exoribonuclease,2/230,15/8183,0.0649498450574618,0.298429680231344,0.252024166580038,LSM3/LSM5,2
R-HSA-2467813,R-HSA-2467813,Separation of Sister Chromatids,9/230,181/8183,0.0688818001539997,0.314440944858843,0.265545695740642,TUBB2B/RPS27/TUBA1A/TUBB2A/TUBB3/MAD1L1/PSMB8/PSMA6/TUBB4B,9
R-HSA-9617828,R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,2/230,16/8183,0.0728910821399332,0.328446734872701,0.277373599563081,CDKN1A/BTG1,2
R-HSA-8957275,R-HSA-8957275,Post-translational protein phosphorylation,5/230,80/8183,0.0740674690296324,0.328446734872701,0.277373599563081,TIMP1/HSP90B1/CHGB/PDIA6/IGFBP5,5
R-HSA-425397,R-HSA-425397,Transport of vitamins, nucleosides, and related molecules,3/230,35/8183,0.0742859613723464,0.328446734872701,0.277373599563081,APOD/SLC25A6/LCN15,3
R-HSA-532668,R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,3/230,35/8183,0.0742859613723464,0.328446734872701,0.277373599563081,PDIA3/CALR/OS9,3
R-HSA-5663213,R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,3/230,35/8183,0.0742859613723464,0.328446734872701,0.277373599563081,CDC42/RAC1/BRK1,3
R-HSA-380270,R-HSA-380270,Recruitment of mitotic centrosome proteins and complexes,5/230,81/8183,0.0772265263216653,0.337206509342427,0.284771237956321,MZT2B/TUBA1A/MZT2A/YWHAG/TUBB4B,5
R-HSA-380287,R-HSA-380287,Centrosome maturation,5/230,81/8183,0.0772265263216653,0.337206509342427,0.284771237956321,MZT2B/TUBA1A/MZT2A/YWHAG/TUBB4B,5
R-HSA-1296041,R-HSA-1296041,Activation of G protein gated Potassium channels,2/230,17/8183,0.0811252578810364,0.343560580062461,0.290137257101487,GNB2/GNG2,2
R-HSA-1296059,R-HSA-1296059,G protein gated Potassium channels,2/230,17/8183,0.0811252578810364,0.343560580062461,0.290137257101487,GNB2/GNG2,2
R-HSA-392170,R-HSA-392170,ADP signalling through P2Y purinoceptor 12,2/230,17/8183,0.0811252578810364,0.343560580062461,0.290137257101487,GNB2/GNG2,2
R-HSA-418217,R-HSA-418217,G beta:gamma signalling through PLC beta,2/230,17/8183,0.0811252578810364,0.343560580062461,0.290137257101487,GNB2/GNG2,2
R-HSA-997272,R-HSA-997272,Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,2/230,17/8183,0.0811252578810364,0.343560580062461,0.290137257101487,GNB2/GNG2,2
R-HSA-6814122,R-HSA-6814122,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,3/230,37/8183,0.0847247159271823,0.356655540699456,0.301195964594584,RGS7/GNB2/GNG2,3
R-HSA-5683057,R-HSA-5683057,MAPK family signaling cascades,11/230,246/8183,0.0863340262089259,0.361266788243303,0.305090167805979,CDC42/RAC1/DUSP1/HGF/PSMB8/RBX1/PSMA6/JUN/CAMK2B/DUSP2/DNAJB1,11
R-HSA-68886,R-HSA-68886,M Phase,15/230,364/8183,0.0881335360215464,0.364218192944571,0.307582632059202,TUBB2B/RPS27/MZT2B/TUBA1A/TUBB2A/TUBB3/HIST1H2AC/HIST1H4C/MZT2A/MAD1L1/PSMB8/H2AFV/PSMA6/YWHAG/TUBB4B,15
R-HSA-195721,R-HSA-195721,Signaling by WNT,12/230,276/8183,0.0885528551367332,0.364218192944571,0.307582632059202,RHOA/GNB2/SOX4/GNG2/HIST1H2AC/RAC1/HIST1H4C/PSMB8/H2AFV/RBX1/SNX3/PSMA6,12
R-HSA-418592,R-HSA-418592,ADP signalling through P2Y purinoceptor 1,2/230,18/8183,0.0896297971257622,0.364218192944571,0.307582632059202,GNB2/GNG2,2
R-HSA-428930,R-HSA-428930,Thromboxane signalling through TP receptor,2/230,18/8183,0.0896297971257622,0.364218192944571,0.307582632059202,GNB2/GNG2,2
R-HSA-500657,R-HSA-500657,Presynaptic function of Kainate receptors,2/230,18/8183,0.0896297971257622,0.364218192944571,0.307582632059202,GNB2/GNG2,2
R-HSA-68882,R-HSA-68882,Mitotic Anaphase,9/230,192/8183,0.0915636765268401,0.369938302289475,0.312413270182322,TUBB2B/RPS27/TUBA1A/TUBB2A/TUBB3/MAD1L1/PSMB8/PSMA6/TUBB4B,9
R-HSA-2555396,R-HSA-2555396,Mitotic Metaphase and Anaphase,9/230,193/8183,0.093821137149369,0.376892910948608,0.318286444224025,TUBB2B/RPS27/TUBA1A/TUBB2A/TUBB3/MAD1L1/PSMB8/PSMA6/TUBB4B,9
R-HSA-1221632,R-HSA-1221632,Meiotic synapsis,4/230,62/8183,0.0961295588260773,0.383972044629161,0.324264779772175,TERF2IP/HIST1H2AC/HIST1H4C/H2AFV,4
R-HSA-381119,R-HSA-381119,Unfolded Protein Response (UPR),5/230,87/8183,0.097670895929527,0.387924518861342,0.327602648256041,HSP90B1/CALR/PDIA6/SERP1/HSPA5,5
R-HSA-8876725,R-HSA-8876725,Protein methylation,2/230,19/8183,0.0983831525793627,0.388558181254449,0.328137776787466,RPS2/EEF2,2
R-HSA-198933,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,4/230,63/8183,0.100508158270781,0.389288535145306,0.328754561386468,B2M/HLA-A/HLA-C/HLA-B,4
R-HSA-373080,R-HSA-373080,Class B/2 (Secretin family receptors),4/230,63/8183,0.100508158270781,0.389288535145306,0.328754561386468,RAMP1/GNB2/GNG2/CALCB,4
R-HSA-373755,R-HSA-373755,Semaphorin interactions,4/230,63/8183,0.100508158270781,0.389288535145306,0.328754561386468,RHOA/RAC1/RHOB/DPYSL3,4
R-HSA-2559583,R-HSA-2559583,Cellular Senescence,8/230,168/8183,0.100783091602341,0.389288535145306,0.328754561386468,TERF2IP/FOS/HIST1H1C/HIST1H2AC/HIST1H4C/H2AFV/CDKN1A/JUN,8
R-HSA-112316,R-HSA-112316,Neuronal System,13/230,314/8183,0.104536952972674,0.397001742178555,0.335268372521831,TUBB2B/GNB2/TUBA1A/TUBB2A/TUBB3/GNG2/RAC1/GRIK2/CACNA2D1/SLITRK6/SYT1/CAMK2B/TUBB4B,13
R-HSA-983169,R-HSA-983169,Class I MHC mediated antigen processing & presentation,14/230,344/8183,0.10478897909907,0.397001742178555,0.335268372521831,B2M/HLA-A/HLA-C/HLA-B/SEC61G/PDIA3/CALR/VAMP8/MYLIP/PSMB8/HSPA5/RBX1/PSMA6/UBE2S,14
R-HSA-1632852,R-HSA-1632852,Macroautophagy,5/230,89/8183,0.105038867774127,0.397001742178555,0.335268372521831,GABARAP/GABARAPL2/TOMM7/WIPI2/MAP1LC3B,5
R-HSA-6811434,R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,5/230,89/8183,0.105038867774127,0.397001742178555,0.335268372521831,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-3928662,R-HSA-3928662,EPHB-mediated forward signaling,3/230,41/8183,0.1073256551424,0.399351481416327,0.337252729683026,RHOA/CDC42/RAC1,3
R-HSA-1296065,R-HSA-1296065,Inwardly rectifying K+ channels,2/230,20/8183,0.107364765274091,0.399351481416327,0.337252729683026,GNB2/GNG2,2
R-HSA-5627117,R-HSA-5627117,RHO GTPases Activate ROCKs,2/230,20/8183,0.107364765274091,0.399351481416327,0.337252729683026,RHOA/RHOB,2
R-HSA-3214858,R-HSA-3214858,RMTs methylate histone arginines,4/230,65/8183,0.10953657696792,0.405285334781305,0.34226387484713,RPS2/HIST1H2AC/HIST1H4C/H2AFV,4
R-HSA-202733,R-HSA-202733,Cell surface interactions at the vascular wall,5/230,91/8183,0.112673768483349,0.40969091790497,0.345984394247815,BSG/EPCAM/MIF/PPIA/CD47,5
R-HSA-4420097,R-HSA-4420097,VEGFA-VEGFR2 Pathway,5/230,91/8183,0.112673768483349,0.40969091790497,0.345984394247815,RHOA/CDC42/RAC1/BRK1/VEGFA,5
R-HSA-6807878,R-HSA-6807878,COPI-mediated anterograde transport,5/230,91/8183,0.112673768483349,0.40969091790497,0.345984394247815,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-8854214,R-HSA-8854214,TBC/RABGAPs,3/230,42/8183,0.113308897254331,0.40969091790497,0.345984394247815,GABARAP/GABARAPL2/MAP1LC3B,3
R-HSA-73856,R-HSA-73856,RNA Polymerase II Transcription Termination,4/230,66/8183,0.114182959978043,0.40969091790497,0.345984394247815,SNRPF/SRSF9/THOC7/SNRPE,4
R-HSA-112409,R-HSA-112409,RAF-independent MAPK1/3 activation,2/230,21/8183,0.116555026431001,0.40969091790497,0.345984394247815,DUSP1/DUSP2,2
R-HSA-202040,R-HSA-202040,G-protein activation,2/230,21/8183,0.116555026431001,0.40969091790497,0.345984394247815,GNB2/GNG2,2
R-HSA-210991,R-HSA-210991,Basigin interactions,2/230,21/8183,0.116555026431001,0.40969091790497,0.345984394247815,BSG/PPIA,2
R-HSA-416572,R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,2/230,21/8183,0.116555026431001,0.40969091790497,0.345984394247815,RHOA/RHOB,2
R-HSA-5205685,R-HSA-5205685,Pink/Parkin Mediated Mitophagy,2/230,21/8183,0.116555026431001,0.40969091790497,0.345984394247815,TOMM7/MAP1LC3B,2
R-HSA-416482,R-HSA-416482,G alpha (12/13) signalling events,4/230,67/8183,0.118915070617813,0.415906938528969,0.351233829947351,RHOA/GNB2/GNG2/RHOB,4
R-HSA-157579,R-HSA-157579,Telomere Maintenance,4/230,68/8183,0.123731050717889,0.429769292189857,0.362940601624735,TERF2IP/HIST1H2AC/HIST1H4C/H2AFV,4
R-HSA-73728,R-HSA-73728,RNA Polymerase I Promoter Opening,3/230,44/8183,0.125642647724218,0.429769292189857,0.362940601624735,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-196071,R-HSA-196071,Metabolism of steroid hormones,2/230,22/8183,0.125935240670143,0.429769292189857,0.362940601624735,TSPO/AKR1B1,2
R-HSA-420092,R-HSA-420092,Glucagon-type ligand receptors,2/230,22/8183,0.125935240670143,0.429769292189857,0.362940601624735,GNB2/GNG2,2
R-HSA-77387,R-HSA-77387,Insulin receptor recycling,2/230,22/8183,0.125935240670143,0.429769292189857,0.362940601624735,ATP6AP1/ATP6V0E2,2
R-HSA-5334118,R-HSA-5334118,DNA methylation,3/230,45/8183,0.131983741021738,0.448234637383005,0.378534604303384,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-164952,R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,2/230,23/8183,0.13548759052398,0.455730986307933,0.384865278547091,B2M/RAC1,2
R-HSA-392518,R-HSA-392518,Signal amplification,2/230,23/8183,0.13548759052398,0.455730986307933,0.384865278547091,GNB2/GNG2,2
R-HSA-194138,R-HSA-194138,Signaling by VEGF,5/230,97/8183,0.137109333242526,0.458989815569029,0.387617363151804,RHOA/CDC42/RAC1/BRK1/VEGFA,5
R-HSA-72163,R-HSA-72163,mRNA Splicing - Major Pathway,8/230,182/8183,0.140400146301431,0.467778686492446,0.395039573529594,YBX1/SNRPF/SNRNP70/SRSF9/SNRPE/TXNL4A/LSM3/LSM5,8
R-HSA-157118,R-HSA-157118,Signaling by NOTCH,9/230,212/8183,0.142769024417208,0.473427472477816,0.399809979003502,MDK/YBX1/HIST1H2AC/HIST1H4C/PSMB8/H2AFV/RBX1/PSMA6/JUN,9
R-HSA-5625886,R-HSA-5625886,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,3/230,47/8183,0.144990668846283,0.474754217924959,0.400930416874563,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-2424491,R-HSA-2424491,DAP12 signaling,2/230,24/8183,0.145195102210336,0.474754217924959,0.400930416874563,B2M/RAC1,2
R-HSA-5627123,R-HSA-5627123,RHO GTPases activate PAKs,2/230,24/8183,0.145195102210336,0.474754217924959,0.400930416874563,CDC42/RAC1,2
R-HSA-9018519,R-HSA-9018519,Estrogen-dependent gene expression,6/230,127/8183,0.147363947861334,0.479615071048694,0.40503541225045,TFF3/FOS/HIST1H2AC/HIST1H4C/H2AFV/JUN,6
R-HSA-388396,R-HSA-388396,GPCR downstream signalling,17/230,461/8183,0.151963791508052,0.492306660968481,0.415753472765177,NPW/TAC3/GRP/RHOA/RAMP1/RGS7/GNB2/PSAP/OR51E1/GNG2/RBP1/CDC42/RHOB/RGS2/GNRH2/CAMK2B/CALCB,17
R-HSA-1912408,R-HSA-1912408,Pre-NOTCH Transcription and Translation,4/230,74/8183,0.154278425306617,0.497512536653907,0.420149840043129,HIST1H2AC/HIST1H4C/H2AFV/JUN,4
R-HSA-400042,R-HSA-400042,Adrenaline,noradrenaline inhibits insulin secretion,2/230,25/8183,0.155041612622566,0.497690656044126,0.420300262048195,GNB2/GNG2,2
R-HSA-350562,R-HSA-350562,Regulation of ornithine decarboxylase (ODC),3/230,49/8183,0.15839893092322,0.501596614590196,0.423598847988127,ODC1/PSMB8/PSMA6,3
R-HSA-381070,R-HSA-381070,IRE1alpha activates chaperones,3/230,49/8183,0.15839893092322,0.501596614590196,0.423598847988127,PDIA6/SERP1/HSPA5,3
R-HSA-427359,R-HSA-427359,SIRT1 negatively regulates rRNA expression,3/230,49/8183,0.15839893092322,0.501596614590196,0.423598847988127,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-3858494,R-HSA-3858494,Beta-catenin independent WNT signaling,6/230,131/8183,0.163106173799053,0.509848295742173,0.430567401060995,RHOA/GNB2/GNG2/RAC1/PSMB8/PSMA6,6
R-HSA-416476,R-HSA-416476,G alpha (q) signalling events,6/230,131/8183,0.163106173799053,0.509848295742173,0.430567401060995,TAC3/GRP/GNB2/GNG2/RGS2/GNRH2,6
R-HSA-456926,R-HSA-456926,Thrombin signalling through proteinase activated receptors (PARs),2/230,26/8183,0.165011737496026,0.509848295742173,0.430567401060995,GNB2/GNG2,2
R-HSA-8949613,R-HSA-8949613,Cristae formation,2/230,26/8183,0.165011737496026,0.509848295742173,0.430567401060995,ATP5F1E/ATP5ME,2
R-HSA-5632684,R-HSA-5632684,Hedgehog 'on' state,4/230,76/8183,0.165040741639651,0.509848295742173,0.430567401060995,EVC2/PSMB8/RBX1/PSMA6,4
R-HSA-72172,R-HSA-72172,mRNA Splicing,8/230,190/8183,0.166081450533368,0.509848295742173,0.430567401060995,YBX1/SNRPF/SNRNP70/SRSF9/SNRPE/TXNL4A/LSM3/LSM5,8
R-HSA-8939211,R-HSA-8939211,ESR-mediated signaling,8/230,190/8183,0.166081450533368,0.509848295742173,0.430567401060995,TFF3/GNB2/FOS/GNG2/HIST1H2AC/HIST1H4C/H2AFV/JUN,8
R-HSA-2559580,R-HSA-2559580,Oxidative Stress Induced Senescence,5/230,104/8183,0.168286656800006,0.514371824914801,0.434387526019238,FOS/HIST1H2AC/HIST1H4C/H2AFV/JUN,5
R-HSA-9006931,R-HSA-9006931,Signaling by Nuclear Receptors,9/230,221/8183,0.169770041005603,0.516659475441293,0.436319449201002,FABP5/TFF3/GNB2/FOS/GNG2/HIST1H2AC/HIST1H4C/H2AFV/JUN,9
R-HSA-917937,R-HSA-917937,Iron uptake and transport,3/230,51/8183,0.172170689603383,0.521706874099905,0.440581982469636,ATP6AP1/FTH1/ATP6V0E2,3
R-HSA-1474165,R-HSA-1474165,Reproduction,5/230,105/8183,0.172954006488116,0.521831186957707,0.440686964803693,CD9/TERF2IP/HIST1H2AC/HIST1H4C/H2AFV,5
R-HSA-180585,R-HSA-180585,Vif-mediated degradation of APOBEC3G,3/230,52/8183,0.179181155963509,0.536018521882327,0.452668183486759,PSMB8/RBX1/PSMA6,3
R-HSA-8854050,R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,3/230,52/8183,0.179181155963509,0.536018521882327,0.452668183486759,PSMB8/RBX1/PSMA6,3
R-HSA-2132295,R-HSA-2132295,MHC class II antigen presentation,5/230,107/8183,0.182436523363993,0.536667016845459,0.453215838138562,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-8939236,R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,5/230,107/8183,0.182436523363993,0.536667016845459,0.453215838138562,HIST1H2AC/HIST1H4C/PSMB8/H2AFV/PSMA6,5
R-HSA-163359,R-HSA-163359,Glucagon signaling in metabolic regulation,2/230,28/8183,0.185265004695458,0.536667016845459,0.453215838138562,GNB2/GNG2,2
R-HSA-2172127,R-HSA-2172127,DAP12 interactions,2/230,28/8183,0.185265004695458,0.536667016845459,0.453215838138562,B2M/RAC1,2
R-HSA-5205647,R-HSA-5205647,Mitophagy,2/230,28/8183,0.185265004695458,0.536667016845459,0.453215838138562,TOMM7/MAP1LC3B,2
R-HSA-75067,R-HSA-75067,Processing of Capped Intronless Pre-mRNA,2/230,28/8183,0.185265004695458,0.536667016845459,0.453215838138562,SNRPF/SNRPE,2
R-HSA-917977,R-HSA-917977,Transferrin endocytosis and recycling,2/230,28/8183,0.185265004695458,0.536667016845459,0.453215838138562,ATP6AP1/ATP6V0E2,2
R-HSA-5362768,R-HSA-5362768,Hh mutants that don't undergo autocatalytic processing are degraded by ERAD,3/230,53/8183,0.186268495178225,0.536667016845459,0.453215838138562,OS9/PSMB8/PSMA6,3
R-HSA-6809371,R-HSA-6809371,Formation of the cornified envelope,3/230,53/8183,0.186268495178225,0.536667016845459,0.453215838138562,DSP/KRT12/KRT10,3
R-HSA-977225,R-HSA-977225,Amyloid fiber formation,4/230,80/8183,0.187332253265665,0.537528873656173,0.453943677086294,B2M/HIST1H2AC/HIST1H4C/NPPA,4
R-HSA-500792,R-HSA-500792,GPCR ligand binding,9/230,227/8183,0.189009774357258,0.539024565982265,0.455206790767385,NPW/TAC3/GRP/RAMP1/GNB2/PSAP/GNG2/GNRH2/CALCB,9
R-HSA-212300,R-HSA-212300,PRC2 methylates histones and DNA,3/230,54/8183,0.193428121389875,0.539024565982265,0.455206790767385,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-2299718,R-HSA-2299718,Condensation of Prophase Chromosomes,3/230,54/8183,0.193428121389875,0.539024565982265,0.455206790767385,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-4641258,R-HSA-4641258,Degradation of DVL,3/230,54/8183,0.193428121389875,0.539024565982265,0.455206790767385,PSMB8/RBX1/PSMA6,3
R-HSA-9604323,R-HSA-9604323,Negative regulation of NOTCH4 signaling,3/230,54/8183,0.193428121389875,0.539024565982265,0.455206790767385,PSMB8/RBX1/PSMA6,3
R-HSA-114452,R-HSA-114452,Activation of BH3-only proteins,2/230,29/8183,0.195521001885459,0.539024565982265,0.455206790767385,YWHAH/YWHAG,2
R-HSA-2129379,R-HSA-2129379,Molecules associated with elastic fibres,2/230,29/8183,0.195521001885459,0.539024565982265,0.455206790767385,MFAP2/ELN,2
R-HSA-8964043,R-HSA-8964043,Plasma lipoprotein clearance,2/230,29/8183,0.195521001885459,0.539024565982265,0.455206790767385,NPC2/MYLIP,2
R-HSA-977444,R-HSA-977444,GABA B receptor activation,2/230,29/8183,0.195521001885459,0.539024565982265,0.455206790767385,GNB2/GNG2,2
R-HSA-991365,R-HSA-991365,Activation of GABAB receptors,2/230,29/8183,0.195521001885459,0.539024565982265,0.455206790767385,GNB2/GNG2,2
R-HSA-5387390,R-HSA-5387390,Hh mutants abrogate ligand secretion,3/230,55/8183,0.200655497691059,0.551018808112558,0.465335940369069,OS9/PSMB8/PSMA6,3
R-HSA-389356,R-HSA-389356,CD28 co-stimulation,2/230,30/8183,0.205846267215842,0.553735368022203,0.467630077958408,CDC42/RAC1,2
R-HSA-499943,R-HSA-499943,Interconversion of nucleotide di- and triphosphates,2/230,30/8183,0.205846267215842,0.553735368022203,0.467630077958408,NME4/CTPS1,2
R-HSA-418555,R-HSA-418555,G alpha (s) signalling events,5/230,112/8183,0.206944888607,0.553735368022203,0.467630077958408,RAMP1/GNB2/OR51E1/GNG2/CALCB,5
R-HSA-429914,R-HSA-429914,Deadenylation-dependent mRNA decay,3/230,56/8183,0.20794614104959,0.553735368022203,0.467630077958408,EIF4A2/LSM3/LSM5,3
R-HSA-5610780,R-HSA-5610780,Degradation of GLI1 by the proteasome,3/230,56/8183,0.20794614104959,0.553735368022203,0.467630077958408,PSMB8/RBX1/PSMA6,3
R-HSA-5610783,R-HSA-5610783,Degradation of GLI2 by the proteasome,3/230,56/8183,0.20794614104959,0.553735368022203,0.467630077958408,PSMB8/RBX1/PSMA6,3
R-HSA-5610785,R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,3/230,56/8183,0.20794614104959,0.553735368022203,0.467630077958408,PSMB8/RBX1/PSMA6,3
R-HSA-9614085,R-HSA-9614085,FOXO-mediated transcription,3/230,56/8183,0.20794614104959,0.553735368022203,0.467630077958408,CDKN1A/YWHAG/BTG1,3
R-HSA-2029482,R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,3/230,57/8183,0.215295626809935,0.568995585140544,0.480517346738439,CDC42/RAC1/BRK1,3
R-HSA-427389,R-HSA-427389,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,3/230,57/8183,0.215295626809935,0.568995585140544,0.480517346738439,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-450282,R-HSA-450282,MAPK targets/ Nuclear events mediated by MAP kinases,2/230,31/8183,0.216228871597976,0.569321710611901,0.480792760028617,FOS/JUN,2
R-HSA-4086400,R-HSA-4086400,PCP/CE pathway,4/230,86/8183,0.222420732946079,0.581270540004064,0.490883558527053,RHOA/RAC1/PSMB8/PSMA6,4
R-HSA-450531,R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,4/230,86/8183,0.222420732946079,0.581270540004064,0.490883558527053,HSPA1A/HSPA1B/PSMB8/PSMA6,4
R-HSA-168274,R-HSA-168274,Export of Viral Ribonucleoproteins from Nucleus,2/230,32/8183,0.226657496356093,0.590148962734568,0.498381395496439,HSPA1A/HSPA1B,2
R-HSA-72203,R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,9/230,239/8183,0.230143005350468,0.594845887295696,0.502347953035521,YBX1/SNRPF/SNRNP70/SRSF9/THOC7/SNRPE/TXNL4A/LSM3/LSM5,9
R-HSA-5678895,R-HSA-5678895,Defective CFTR causes cystic fibrosis,3/230,59/8183,0.230153743021948,0.594845887295696,0.502347953035521,OS9/PSMB8/PSMA6,3
R-HSA-187577,R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,3/230,60/8183,0.237653851076751,0.607905712554533,0.513376988666252,PSMB8/PSMA6/CDKN1A,3
R-HSA-1268020,R-HSA-1268020,Mitochondrial protein import,3/230,61/8183,0.245195763127342,0.607905712554533,0.513376988666252,TOMM7/SLC25A6/CHCHD2,3
R-HSA-5358346,R-HSA-5358346,Hedgehog ligand biogenesis,3/230,61/8183,0.245195763127342,0.607905712554533,0.513376988666252,OS9/PSMB8/PSMA6,3
R-HSA-606279,R-HSA-606279,Deposition of new CENPA-containing nucleosomes at the centromere,3/230,61/8183,0.245195763127342,0.607905712554533,0.513376988666252,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-774815,R-HSA-774815,Nucleosome assembly,3/230,61/8183,0.245195763127342,0.607905712554533,0.513376988666252,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-1912422,R-HSA-1912422,Pre-NOTCH Expression and Processing,4/230,90/8183,0.24670541675226,0.607905712554533,0.513376988666252,HIST1H2AC/HIST1H4C/H2AFV/JUN,4
R-HSA-381676,R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,2/230,34/8183,0.247610437419079,0.607905712554533,0.513376988666252,GNB2/GNG2,2
R-HSA-5576892,R-HSA-5576892,Phase 0 - rapid depolarisation,2/230,34/8183,0.247610437419079,0.607905712554533,0.513376988666252,CACNA2D1/CAMK2B,2
R-HSA-1170546,R-HSA-1170546,Prolactin receptor signaling,1/230,10/8183,0.248177723333074,0.607905712554533,0.513376988666252,RBX1,1
R-HSA-2025928,R-HSA-2025928,Calcineurin activates NFAT,1/230,10/8183,0.248177723333074,0.607905712554533,0.513376988666252,PPIA,1
R-HSA-351906,R-HSA-351906,Apoptotic cleavage of cell adhesion  proteins,1/230,10/8183,0.248177723333074,0.607905712554533,0.513376988666252,DSP,1
R-HSA-442729,R-HSA-442729,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,1/230,10/8183,0.248177723333074,0.607905712554533,0.513376988666252,CAMK2B,1
R-HSA-5578768,R-HSA-5578768,Physiological factors,1/230,10/8183,0.248177723333074,0.607905712554533,0.513376988666252,NPPA,1
R-HSA-83936,R-HSA-83936,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,1/230,10/8183,0.248177723333074,0.607905712554533,0.513376988666252,SLC25A6,1
R-HSA-8875656,R-HSA-8875656,MET receptor recycling,1/230,10/8183,0.248177723333074,0.607905712554533,0.513376988666252,HGF,1
R-HSA-8856688,R-HSA-8856688,Golgi-to-ER retrograde transport,5/230,121/8183,0.253498806689741,0.611325539881615,0.516265036300413,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-1566948,R-HSA-1566948,Elastic fibre formation,2/230,35/8183,0.258114951118881,0.611325539881615,0.516265036300413,MFAP2/ELN,2
R-HSA-2142753,R-HSA-2142753,Arachidonic acid metabolism,2/230,35/8183,0.258114951118881,0.611325539881615,0.516265036300413,PON3/PON2,2
R-HSA-432040,R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,2/230,35/8183,0.258114951118881,0.611325539881615,0.516265036300413,GNB2/GNG2,2
R-HSA-1234176,R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,3/230,63/8183,0.260388762752356,0.611325539881615,0.516265036300413,PSMB8/RBX1/PSMA6,3
R-HSA-9609507,R-HSA-9609507,Protein localization,6/230,153/8183,0.260554493098423,0.611325539881615,0.516265036300413,SEC61G/CYB5A/TOMM7/SLC25A6/SERP1/CHCHD2,6
R-HSA-375276,R-HSA-375276,Peptide ligand-binding receptors,4/230,93/8183,0.265286696720999,0.611325539881615,0.516265036300413,NPW/TAC3/GRP/PSAP,4
R-HSA-69563,R-HSA-69563,p53-Dependent G1 DNA Damage Response,3/230,64/8183,0.268031928450328,0.611325539881615,0.516265036300413,PSMB8/PSMA6/CDKN1A,3
R-HSA-69580,R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,3/230,64/8183,0.268031928450328,0.611325539881615,0.516265036300413,PSMB8/PSMA6/CDKN1A,3
R-HSA-8875878,R-HSA-8875878,MET promotes cell motility,2/230,36/8183,0.268625835051369,0.611325539881615,0.516265036300413,RAC1/HGF,2
R-HSA-1187000,R-HSA-1187000,Fertilization,1/230,11/8183,0.269335085823395,0.611325539881615,0.516265036300413,CD9,1
R-HSA-140342,R-HSA-140342,Apoptosis induced DNA fragmentation,1/230,11/8183,0.269335085823395,0.611325539881615,0.516265036300413,HIST1H1C,1
R-HSA-174403,R-HSA-174403,Glutathione synthesis and recycling,1/230,11/8183,0.269335085823395,0.611325539881615,0.516265036300413,GGCT,1
R-HSA-2032785,R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,1/230,11/8183,0.269335085823395,0.611325539881615,0.516265036300413,NPPA,1
R-HSA-2453902,R-HSA-2453902,The canonical retinoid cycle in rods (twilight vision),1/230,11/8183,0.269335085823395,0.611325539881615,0.516265036300413,RBP1,1
R-HSA-388844,R-HSA-388844,Receptor-type tyrosine-protein phosphatases,1/230,11/8183,0.269335085823395,0.611325539881615,0.516265036300413,SLITRK6,1
R-HSA-391160,R-HSA-391160,Signal regulatory protein family interactions,1/230,11/8183,0.269335085823395,0.611325539881615,0.516265036300413,CD47,1
R-HSA-5686938,R-HSA-5686938,Regulation of TLR by endogenous ligand,1/230,11/8183,0.269335085823395,0.611325539881615,0.516265036300413,S100A1,1
R-HSA-8851805,R-HSA-8851805,MET activates RAS signaling,1/230,11/8183,0.269335085823395,0.611325539881615,0.516265036300413,HGF,1
R-HSA-8866910,R-HSA-8866910,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,1/230,11/8183,0.269335085823395,0.611325539881615,0.516265036300413,VEGFA,1
R-HSA-8934903,R-HSA-8934903,Receptor Mediated Mitophagy,1/230,11/8183,0.269335085823395,0.611325539881615,0.516265036300413,MAP1LC3B,1
R-HSA-9614399,R-HSA-9614399,Regulation of localization of FOXO transcription factors,1/230,11/8183,0.269335085823395,0.611325539881615,0.516265036300413,YWHAG,1
R-HSA-2454202,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,5/230,124/8183,0.269574562394453,0.611325539881615,0.516265036300413,FOS/RAC1/PSMB8/PSMA6/JUN,5
R-HSA-1500620,R-HSA-1500620,Meiosis,4/230,94/8183,0.271538922518705,0.613800201063182,0.518354890169401,TERF2IP/HIST1H2AC/HIST1H4C/H2AFV,4
R-HSA-162906,R-HSA-162906,HIV Infection,8/230,219/8183,0.274258768739769,0.617254280342736,0.521271863612043,B2M/SLC25A6/RAC1/PPIA/PSMB8/RBX1/PSMA6/RANBP1,8
R-HSA-5658442,R-HSA-5658442,Regulation of RAS by GAPs,3/230,65/8183,0.275701058360767,0.617254280342736,0.521271863612043,PSMB8/RBX1/PSMA6,3
R-HSA-912446,R-HSA-912446,Meiotic recombination,3/230,65/8183,0.275701058360767,0.617254280342736,0.521271863612043,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-5689603,R-HSA-5689603,UCH proteinases,4/230,95/8183,0.277816824860716,0.617573923479068,0.521541802563741,UCHL1/HIST1H2AC/PSMB8/PSMA6,4
R-HSA-69615,R-HSA-69615,G1/S DNA Damage Checkpoints,3/230,66/8183,0.283392396378992,0.617573923479068,0.521541802563741,PSMB8/PSMA6/CDKN1A,3
R-HSA-5617472,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,4/230,96/8183,0.284118300047014,0.617573923479068,0.521541802563741,HIST1H2AC/HIST1H4C/H2AFV/JUN,4
R-HSA-5619507,R-HSA-5619507,Activation of HOX genes during differentiation,4/230,96/8183,0.284118300047014,0.617573923479068,0.521541802563741,HIST1H2AC/HIST1H4C/H2AFV/JUN,4
R-HSA-73886,R-HSA-73886,Chromosome Maintenance,4/230,96/8183,0.284118300047014,0.617573923479068,0.521541802563741,TERF2IP/HIST1H2AC/HIST1H4C/H2AFV,4
R-HSA-418597,R-HSA-418597,G alpha (z) signalling events,2/230,38/8183,0.289632713849654,0.617573923479068,0.521541802563741,GNB2/GNG2,2
R-HSA-445717,R-HSA-445717,Aquaporin-mediated transport,2/230,38/8183,0.289632713849654,0.617573923479068,0.521541802563741,GNB2/GNG2,2
R-HSA-977443,R-HSA-977443,GABA receptor activation,2/230,38/8183,0.289632713849654,0.617573923479068,0.521541802563741,GNB2/GNG2,2
R-HSA-111932,R-HSA-111932,CaMK IV-mediated phosphorylation of CREB,1/230,12/8183,0.28989956578676,0.617573923479068,0.521541802563741,CAMK2B,1
R-HSA-162594,R-HSA-162594,Early Phase of HIV Life Cycle,1/230,12/8183,0.28989956578676,0.617573923479068,0.521541802563741,PPIA,1
R-HSA-3371511,R-HSA-3371511,HSF1 activation,1/230,12/8183,0.28989956578676,0.617573923479068,0.521541802563741,HSBP1,1
R-HSA-451306,R-HSA-451306,Ionotropic activity of kainate receptors,1/230,12/8183,0.28989956578676,0.617573923479068,0.521541802563741,GRIK2,1
R-HSA-451308,R-HSA-451308,Activation of Ca-permeable Kainate Receptor,1/230,12/8183,0.28989956578676,0.617573923479068,0.521541802563741,GRIK2,1
R-HSA-6785631,R-HSA-6785631,ERBB2 Regulates Cell Motility,1/230,12/8183,0.28989956578676,0.617573923479068,0.521541802563741,RHOA,1
R-HSA-74217,R-HSA-74217,Purine salvage,1/230,12/8183,0.28989956578676,0.617573923479068,0.521541802563741,APRT,1
R-HSA-8866427,R-HSA-8866427,VLDLR internalisation and degradation,1/230,12/8183,0.28989956578676,0.617573923479068,0.521541802563741,MYLIP,1
R-HSA-9009391,R-HSA-9009391,Non-genomic estrogen signaling,3/230,67/8183,0.291102271024047,0.61826252728068,0.522123329170178,GNB2/FOS/GNG2,3
R-HSA-8939902,R-HSA-8939902,Regulation of RUNX2 expression and activity,3/230,68/8183,0.298827096576639,0.629789113230927,0.531857542655151,PSMB8/RBX1/PSMA6,3
R-HSA-201681,R-HSA-201681,TCF dependent signaling in response to WNT,7/230,193/8183,0.299719111592379,0.629789113230927,0.531857542655151,SOX4/HIST1H2AC/HIST1H4C/PSMB8/H2AFV/RBX1/PSMA6,7
R-HSA-5675221,R-HSA-5675221,Negative regulation of MAPK pathway,2/230,39/8183,0.300112877570925,0.629789113230927,0.531857542655151,DUSP1/DUSP2,2
R-HSA-73933,R-HSA-73933,Resolution of Abasic Sites (AP sites),2/230,39/8183,0.300112877570925,0.629789113230927,0.531857542655151,BPHL/NTHL1,2
R-HSA-201722,R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,3/230,69/8183,0.306563374007512,0.63328795886708,0.534812321331187,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-380259,R-HSA-380259,Loss of Nlp from mitotic centrosomes,3/230,69/8183,0.306563374007512,0.63328795886708,0.534812321331187,TUBA1A/YWHAG/TUBB4B,3
R-HSA-380284,R-HSA-380284,Loss of proteins required for interphase microtubule organization from the centrosome,3/230,69/8183,0.306563374007512,0.63328795886708,0.534812321331187,TUBA1A/YWHAG/TUBB4B,3
R-HSA-68949,R-HSA-68949,Orc1 removal from chromatin,3/230,69/8183,0.306563374007512,0.63328795886708,0.534812321331187,PSMB8/RBX1/PSMA6,3
R-HSA-109581,R-HSA-109581,Apoptosis,6/230,163/8183,0.309201458867467,0.63328795886708,0.534812321331187,HIST1H1C/YWHAH/DSP/PSMB8/PSMA6/YWHAG,6
R-HSA-112308,R-HSA-112308,Presynaptic depolarization and calcium channel opening,1/230,13/8183,0.309887706757149,0.63328795886708,0.534812321331187,CACNA2D1,1
R-HSA-2559584,R-HSA-2559584,Formation of Senescence-Associated Heterochromatin Foci (SAHF),1/230,13/8183,0.309887706757149,0.63328795886708,0.534812321331187,HIST1H1C,1
R-HSA-399955,R-HSA-399955,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,1/230,13/8183,0.309887706757149,0.63328795886708,0.534812321331187,RAC1,1
R-HSA-428540,R-HSA-428540,Activation of RAC1,1/230,13/8183,0.309887706757149,0.63328795886708,0.534812321331187,RAC1,1
R-HSA-5619084,R-HSA-5619084,ABC transporter disorders,3/230,70/8183,0.314307691709206,0.640458861656731,0.540868155984721,OS9/PSMB8/PSMA6,3
R-HSA-168898,R-HSA-168898,Toll-like Receptor Cascades,5/230,133/8183,0.318960077563143,0.648060504412976,0.547287750975396,S100A1/HSP90B1/FOS/JUN/CNPY3,5
R-HSA-373752,R-HSA-373752,Netrin-1 signaling,2/230,41/8183,0.320990380034254,0.650306158974295,0.549184208522127,CDC42/RAC1,2
R-HSA-170834,R-HSA-170834,Signaling by TGF-beta Receptor Complex,3/230,71/8183,0.322056726043516,0.65059160462239,0.549425267660445,RHOA/PPP1R15A/JUNB,3
R-HSA-5357801,R-HSA-5357801,Programmed Cell Death,6/230,166/8183,0.324111592583665,0.652866617725834,0.551346518525673,HIST1H1C/YWHAH/DSP/PSMB8/PSMA6/YWHAG,6
R-HSA-198323,R-HSA-198323,AKT phosphorylates targets in the cytosol,1/230,14/8183,0.329315592613435,0.654956189058261,0.553111163627849,CDKN1A,1
R-HSA-6804116,R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,1/230,14/8183,0.329315592613435,0.654956189058261,0.553111163627849,CDKN1A,1
R-HSA-5250924,R-HSA-5250924,B-WICH complex positively regulates rRNA expression,3/230,72/8183,0.329807241716393,0.654956189058261,0.553111163627849,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-73772,R-HSA-73772,RNA Polymerase I Promoter Escape,3/230,72/8183,0.329807241716393,0.654956189058261,0.553111163627849,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-8854518,R-HSA-8854518,AURKA Activation by TPX2,3/230,72/8183,0.329807241716393,0.654956189058261,0.553111163627849,TUBA1A/YWHAG/TUBB4B,3
R-HSA-3899300,R-HSA-3899300,SUMOylation of transcription cofactors,2/230,42/8183,0.33137445417325,0.656214764179703,0.554174031589956,PARK7/DDX17,2
R-HSA-8936459,R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,3/230,73/8183,0.337556091991465,0.666578462556179,0.562926185343543,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-6806834,R-HSA-6806834,Signaling by MET,3/230,74/8183,0.345300218752796,0.679954996633585,0.574222681891656,SPINT2/RAC1/HGF,3
R-HSA-264642,R-HSA-264642,Acetylcholine Neurotransmitter Release Cycle,1/230,15/8183,0.348198860296004,0.679954996633585,0.574222681891656,SYT1,1
R-HSA-5635838,R-HSA-5635838,Activation of SMO,1/230,15/8183,0.348198860296004,0.679954996633585,0.574222681891656,EVC2,1
R-HSA-888590,R-HSA-888590,GABA synthesis, release, reuptake and degradation,1/230,15/8183,0.348198860296004,0.679954996633585,0.574222681891656,SYT1,1
R-HSA-8878166,R-HSA-8878166,Transcriptional regulation by RUNX2,4/230,108/8183,0.360842362815031,0.700102506760771,0.591237274557274,PSMB8/RBX1/PSMA6/CDKN1A,4
R-HSA-1236978,R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),2/230,45/8183,0.362236444862103,0.700102506760771,0.591237274557274,PSMB8/PSMA6,2
R-HSA-199977,R-HSA-199977,ER to Golgi Anterograde Transport,5/230,141/8183,0.363719291335836,0.700102506760771,0.591237274557274,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-175474,R-HSA-175474,Assembly Of The HIV Virion,1/230,16/8183,0.366552712173076,0.700102506760771,0.591237274557274,PPIA,1
R-HSA-181430,R-HSA-181430,Norepinephrine Neurotransmitter Release Cycle,1/230,16/8183,0.366552712173076,0.700102506760771,0.591237274557274,SYT1,1
R-HSA-2173791,R-HSA-2173791,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),1/230,16/8183,0.366552712173076,0.700102506760771,0.591237274557274,RHOA,1
R-HSA-399954,R-HSA-399954,Sema3A PAK dependent Axon repulsion,1/230,16/8183,0.366552712173076,0.700102506760771,0.591237274557274,RAC1,1
R-HSA-399956,R-HSA-399956,CRMPs in Sema3A signaling,1/230,16/8183,0.366552712173076,0.700102506760771,0.591237274557274,DPYSL3,1
R-HSA-5673001,R-HSA-5673001,RAF/MAP kinase cascade,7/230,208/8183,0.36826390822427,0.700102506760771,0.591237274557274,DUSP1/HGF/PSMB8/RBX1/PSMA6/CAMK2B/DUSP2,7
R-HSA-6805567,R-HSA-6805567,Keratinization,3/230,77/8183,0.368475003558301,0.700102506760771,0.591237274557274,DSP/KRT12/KRT10,3
R-HSA-1168372,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),3/230,78/8183,0.376171422100787,0.70897723790041,0.598731993974443,PPIA/PSMB8/PSMA6,3
R-HSA-195253,R-HSA-195253,Degradation of beta-catenin by the destruction complex,3/230,78/8183,0.376171422100787,0.70897723790041,0.598731993974443,PSMB8/RBX1/PSMA6,3
R-HSA-70326,R-HSA-70326,Glucose metabolism,3/230,78/8183,0.376171422100787,0.70897723790041,0.598731993974443,PGAM2/MDH2/ALDOA,3
R-HSA-381038,R-HSA-381038,XBP1(S) activates chaperone genes,2/230,47/8183,0.382516745685063,0.713001386360497,0.602130391416217,PDIA6/SERP1,2
R-HSA-421270,R-HSA-421270,Cell-cell junction organization,2/230,47/8183,0.382516745685063,0.713001386360497,0.602130391416217,CLDN18/CDH18,2
R-HSA-2029480,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,3/230,79/8183,0.383849148734218,0.713001386360497,0.602130391416217,CDC42/RAC1/BRK1,3
R-HSA-351202,R-HSA-351202,Metabolism of polyamines,3/230,79/8183,0.383849148734218,0.713001386360497,0.602130391416217,ODC1/PSMB8/PSMA6,3
R-HSA-163560,R-HSA-163560,Triglyceride catabolism,1/230,17/8183,0.384391928066328,0.713001386360497,0.602130391416217,FABP5,1
R-HSA-5576893,R-HSA-5576893,Phase 2 - plateau phase,1/230,17/8183,0.384391928066328,0.713001386360497,0.602130391416217,CACNA2D1,1
R-HSA-373076,R-HSA-373076,Class A/1 (Rhodopsin-like receptors),5/230,145/8183,0.386192302889688,0.714455760345923,0.603358611716853,NPW/TAC3/GRP/PSAP/GNRH2,5
R-HSA-5684996,R-HSA-5684996,MAPK1/MAPK3 signaling,7/230,213/8183,0.391437710699914,0.716794431298965,0.605333621700407,DUSP1/HGF/PSMB8/RBX1/PSMA6/CAMK2B/DUSP2,7
R-HSA-111885,R-HSA-111885,Opioid Signalling,3/230,80/8183,0.391505651155071,0.716794431298965,0.605333621700407,GNB2/GNG2/CAMK2B,3
R-HSA-109606,R-HSA-109606,Intrinsic Pathway for Apoptosis,2/230,48/8183,0.39255456052646,0.716794431298965,0.605333621700407,YWHAH/YWHAG,2
R-HSA-211733,R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,2/230,48/8183,0.39255456052646,0.716794431298965,0.605333621700407,PSMB8/PSMA6,2
R-HSA-75153,R-HSA-75153,Apoptotic execution phase,2/230,48/8183,0.39255456052646,0.716794431298965,0.605333621700407,HIST1H1C/DSP,2
R-HSA-2219528,R-HSA-2219528,PI3K/AKT Signaling in Cancer,3/230,81/8183,0.399138482688392,0.718199484262714,0.606520190348387,RAC1/HGF/CDKN1A,3
R-HSA-5628897,R-HSA-5628897,TP53 Regulates Metabolic Genes,3/230,81/8183,0.399138482688392,0.718199484262714,0.606520190348387,COX4I1/YWHAH/YWHAG,3
R-HSA-446203,R-HSA-446203,Asparagine N-linked glycosylation,9/230,283/8183,0.400772742962284,0.718199484262714,0.606520190348387,TUBB2B/PDIA3/CALR/TUBA1A/TUBB2A/TUBB3/OS9/RPN1/TUBB4B,9
R-HSA-164938,R-HSA-164938,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,1/230,18/8183,0.401730876945185,0.718199484262714,0.606520190348387,B2M,1
R-HSA-181429,R-HSA-181429,Serotonin Neurotransmitter Release Cycle,1/230,18/8183,0.401730876945185,0.718199484262714,0.606520190348387,SYT1,1
R-HSA-438066,R-HSA-438066,Unblocking of NMDA receptors, glutamate binding and activation,1/230,18/8183,0.401730876945185,0.718199484262714,0.606520190348387,CAMK2B,1
R-HSA-8964038,R-HSA-8964038,LDL clearance,1/230,18/8183,0.401730876945185,0.718199484262714,0.606520190348387,NPC2,1
R-HSA-174824,R-HSA-174824,Plasma lipoprotein assembly, remodeling, and clearance,2/230,49/8183,0.402518629871279,0.718199484262714,0.606520190348387,NPC2/MYLIP,2
R-HSA-180534,R-HSA-180534,Vpu mediated degradation of CD4,2/230,49/8183,0.402518629871279,0.718199484262714,0.606520190348387,PSMB8/PSMA6,2
R-HSA-9013694,R-HSA-9013694,Signaling by NOTCH4,3/230,82/8183,0.406745281469622,0.722994595483964,0.610569666621181,PSMB8/RBX1/PSMA6,3
R-HSA-9007101,R-HSA-9007101,Rab regulation of trafficking,4/230,116/8183,0.412088333076585,0.722994595483964,0.610569666621181,RAB13/GABARAP/GABARAPL2/MAP1LC3B,4
R-HSA-349425,R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,2/230,50/8183,0.412405167552019,0.722994595483964,0.610569666621181,PSMB8/PSMA6,2
R-HSA-69601,R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,2/230,50/8183,0.412405167552019,0.722994595483964,0.610569666621181,PSMB8/PSMA6,2
R-HSA-69610,R-HSA-69610,p53-Independent DNA Damage Response,2/230,50/8183,0.412405167552019,0.722994595483964,0.610569666621181,PSMB8/PSMA6,2
R-HSA-69613,R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,2/230,50/8183,0.412405167552019,0.722994595483964,0.610569666621181,PSMB8/PSMA6,2
R-HSA-75815,R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,2/230,50/8183,0.412405167552019,0.722994595483964,0.610569666621181,PSMB8/PSMA6,2
R-HSA-69202,R-HSA-69202,Cyclin E associated events during G1/S transition ,3/230,83/8183,0.414323769550538,0.723007912516181,0.610580912868348,PSMB8/PSMA6/CDKN1A,3
R-HSA-1592389,R-HSA-1592389,Activation of Matrix Metalloproteinases,1/230,19/8183,0.418583528298841,0.723007912516181,0.610580912868348,TIMP1,1
R-HSA-3928664,R-HSA-3928664,Ephrin signaling,1/230,19/8183,0.418583528298841,0.723007912516181,0.610580912868348,RAC1,1
R-HSA-442982,R-HSA-442982,Ras activation upon Ca2+ influx through NMDA receptor,1/230,19/8183,0.418583528298841,0.723007912516181,0.610580912868348,CAMK2B,1
R-HSA-5218921,R-HSA-5218921,VEGFR2 mediated cell proliferation,1/230,19/8183,0.418583528298841,0.723007912516181,0.610580912868348,VEGFA,1
R-HSA-5668599,R-HSA-5668599,RHO GTPases Activate NADPH Oxidases,1/230,19/8183,0.418583528298841,0.723007912516181,0.610580912868348,RAC1,1
R-HSA-169911,R-HSA-169911,Regulation of Apoptosis,2/230,51/8183,0.422210656447882,0.723365491815343,0.610882888947897,PSMB8/PSMA6,2
R-HSA-69473,R-HSA-69473,G2/M DNA damage checkpoint,3/230,85/8183,0.429387115555037,0.723365491815343,0.610882888947897,YWHAH/HIST1H4C/YWHAG,3
R-HSA-69656,R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,3/230,85/8183,0.429387115555037,0.723365491815343,0.610882888947897,PSMB8/PSMA6/CDKN1A,3
R-HSA-191859,R-HSA-191859,snRNP Assembly,2/230,52/8183,0.431931836467257,0.723365491815343,0.610882888947897,SNRPF/SNRPE,2
R-HSA-194441,R-HSA-194441,Metabolism of non-coding RNA,2/230,52/8183,0.431931836467257,0.723365491815343,0.610882888947897,SNRPF/SNRPE,2
R-HSA-71406,R-HSA-71406,Pyruvate metabolism and Citric Acid (TCA) cycle,2/230,52/8183,0.431931836467257,0.723365491815343,0.610882888947897,BSG/MDH2,2
R-HSA-210500,R-HSA-210500,Glutamate Neurotransmitter Release Cycle,1/230,20/8183,0.434963463194881,0.723365491815343,0.610882888947897,SYT1,1
R-HSA-420029,R-HSA-420029,Tight junction interactions,1/230,20/8183,0.434963463194881,0.723365491815343,0.610882888947897,CLDN18,1
R-HSA-445144,R-HSA-445144,Signal transduction by L1,1/230,20/8183,0.434963463194881,0.723365491815343,0.610882888947897,RAC1,1
R-HSA-6803157,R-HSA-6803157,Antimicrobial peptides,1/230,20/8183,0.434963463194881,0.723365491815343,0.610882888947897,CHGA,1
R-HSA-8862803,R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,1/230,20/8183,0.434963463194881,0.723365491815343,0.610882888947897,JUN,1
R-HSA-8863678,R-HSA-8863678,Neurodegenerative Diseases,1/230,20/8183,0.434963463194881,0.723365491815343,0.610882888947897,JUN,1
R-HSA-2565942,R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,3/230,86/8183,0.436867828179458,0.723365491815343,0.610882888947897,TUBA1A/YWHAG/TUBB4B,3
R-HSA-5578749,R-HSA-5578749,Transcriptional regulation by small RNAs,3/230,86/8183,0.436867828179458,0.723365491815343,0.610882888947897,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-174113,R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,2/230,53/8183,0.441565692988395,0.723365491815343,0.610882888947897,PSMB8/PSMA6,2
R-HSA-4086398,R-HSA-4086398,Ca2+ pathway,2/230,53/8183,0.441565692988395,0.723365491815343,0.610882888947897,GNB2/GNG2,2
R-HSA-4641257,R-HSA-4641257,Degradation of AXIN,2/230,53/8183,0.441565692988395,0.723365491815343,0.610882888947897,PSMB8/PSMA6,2
R-HSA-2682334,R-HSA-2682334,EPH-Ephrin signaling,3/230,87/8183,0.444311937282858,0.723365491815343,0.610882888947897,RHOA/CDC42/RAC1,3
R-HSA-427413,R-HSA-427413,NoRC negatively regulates rRNA expression,3/230,87/8183,0.444311937282858,0.723365491815343,0.610882888947897,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-5250913,R-HSA-5250913,Positive epigenetic regulation of rRNA expression,3/230,87/8183,0.444311937282858,0.723365491815343,0.610882888947897,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-5617833,R-HSA-5617833,Cilium Assembly,6/230,190/8183,0.445014687779985,0.723365491815343,0.610882888947897,TUBB2B/TUBA1A/TUBB2A/TUBB3/YWHAG/TUBB4B,6
R-HSA-69481,R-HSA-69481,G2/M Checkpoints,5/230,156/8183,0.447595425200106,0.723365491815343,0.610882888947897,YWHAH/HIST1H4C/PSMB8/PSMA6/YWHAG,5
R-HSA-3238698,R-HSA-3238698,WNT ligand biogenesis and trafficking,1/230,21/8183,0.450883885033075,0.723365491815343,0.610882888947897,SNX3,1
R-HSA-5223345,R-HSA-5223345,Miscellaneous transport and binding events,1/230,21/8183,0.450883885033075,0.723365491815343,0.610882888947897,AZGP1,1
R-HSA-6783783,R-HSA-6783783,Interleukin-10 signaling,1/230,21/8183,0.450883885033075,0.723365491815343,0.610882888947897,TIMP1,1
R-HSA-6807004,R-HSA-6807004,Negative regulation of MET activity,1/230,21/8183,0.450883885033075,0.723365491815343,0.610882888947897,HGF,1
R-HSA-8956321,R-HSA-8956321,Nucleotide salvage,1/230,21/8183,0.450883885033075,0.723365491815343,0.610882888947897,APRT,1
R-HSA-901032,R-HSA-901032,ER Quality Control Compartment (ERQC),1/230,21/8183,0.450883885033075,0.723365491815343,0.610882888947897,OS9,1
R-HSA-9617324,R-HSA-9617324,Negative regulation of NMDA receptor-mediated neuronal transmission,1/230,21/8183,0.450883885033075,0.723365491815343,0.610882888947897,CAMK2B,1
R-HSA-9634638,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,1/230,21/8183,0.450883885033075,0.723365491815343,0.610882888947897,FOS,1
R-HSA-388841,R-HSA-388841,Costimulation by the CD28 family,2/230,54/8183,0.451109445742185,0.723365491815343,0.610882888947897,CDC42/RAC1,2
R-HSA-69052,R-HSA-69052,Switching of origins to a post-replicative state,3/230,88/8183,0.451717568857661,0.723365491815343,0.610882888947897,PSMB8/RBX1/PSMA6,3
R-HSA-194840,R-HSA-194840,Rho GTPase cycle,4/230,123/8183,0.456222986649847,0.728630268606646,0.615328998269295,RHOA/CDC42/RAC1/RHOB,4
R-HSA-382556,R-HSA-382556,ABC-family proteins mediated transport,3/230,89/8183,0.459082926187462,0.728630268606646,0.615328998269295,OS9/PSMB8/PSMA6,3
R-HSA-2219530,R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,2/230,55/8183,0.460560538121473,0.728630268606646,0.615328998269295,RAC1/HGF,2
R-HSA-69541,R-HSA-69541,Stabilization of p53,2/230,55/8183,0.460560538121473,0.728630268606646,0.615328998269295,PSMB8/PSMA6,2
R-HSA-8941858,R-HSA-8941858,Regulation of RUNX3 expression and activity,2/230,55/8183,0.460560538121473,0.728630268606646,0.615328998269295,PSMB8/PSMA6,2
R-HSA-2979096,R-HSA-2979096,NOTCH2 Activation and Transmission of Signal to the Nucleus,1/230,22/8183,0.466357630002738,0.728630268606646,0.615328998269295,MDK,1
R-HSA-71403,R-HSA-71403,Citric acid cycle (TCA cycle),1/230,22/8183,0.466357630002738,0.728630268606646,0.615328998269295,MDH2,1
R-HSA-9006115,R-HSA-9006115,Signaling by NTRK2 (TRKB),1/230,22/8183,0.466357630002738,0.728630268606646,0.615328998269295,RAC1,1
R-HSA-9620244,R-HSA-9620244,Long-term potentiation,1/230,22/8183,0.466357630002738,0.728630268606646,0.615328998269295,CAMK2B,1
R-HSA-15869,R-HSA-15869,Metabolism of nucleotides,3/230,90/8183,0.466406288581779,0.728630268606646,0.615328998269295,APRT/NME4/CTPS1,3
R-HSA-5250941,R-HSA-5250941,Negative epigenetic regulation of rRNA expression,3/230,90/8183,0.466406288581779,0.728630268606646,0.615328998269295,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-432722,R-HSA-432722,Golgi Associated Vesicle Biogenesis,2/230,56/8183,0.469916626901912,0.732486449472383,0.618585546907874,VAMP8/FTH1,2
R-HSA-73854,R-HSA-73854,RNA Polymerase I Promoter Clearance,3/230,91/8183,0.473686010077113,0.735700468713035,0.621299789405034,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-5676590,R-HSA-5676590,NIK-->noncanonical NF-kB signaling,2/230,57/8183,0.479175572359802,0.735700468713035,0.621299789405034,PSMB8/PSMA6,2
R-HSA-68827,R-HSA-68827,CDT1 association with the CDC6:ORC:origin complex,2/230,57/8183,0.479175572359802,0.735700468713035,0.621299789405034,PSMB8/PSMA6,2
R-HSA-72187,R-HSA-72187,mRNA 3'-end processing,2/230,57/8183,0.479175572359802,0.735700468713035,0.621299789405034,SRSF9/THOC7,2
R-HSA-8986944,R-HSA-8986944,Transcriptional Regulation by MECP2,2/230,57/8183,0.479175572359802,0.735700468713035,0.621299789405034,SGK1/CAMK2B,2
R-HSA-73864,R-HSA-73864,RNA Polymerase I Transcription,3/230,92/8183,0.480920518108396,0.735700468713035,0.621299789405034,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-9006936,R-HSA-9006936,Signaling by TGF-beta family members,3/230,92/8183,0.480920518108396,0.735700468713035,0.621299789405034,RHOA/PPP1R15A/JUNB,3
R-HSA-212676,R-HSA-212676,Dopamine Neurotransmitter Release Cycle,1/230,23/8183,0.481397177251773,0.735700468713035,0.621299789405034,SYT1,1
R-HSA-381753,R-HSA-381753,Olfactory Signaling Pathway,1/230,23/8183,0.481397177251773,0.735700468713035,0.621299789405034,OR51E1,1
R-HSA-1257604,R-HSA-1257604,PIP3 activates AKT signaling,7/230,233/8183,0.483591113889287,0.737450223566526,0.622777459147295,RAC1/EGR1/HGF/PSMB8/PSMA6/CDKN1A/JUN,7
R-HSA-8878159,R-HSA-8878159,Transcriptional regulation by RUNX3,3/230,93/8183,0.488108312154642,0.739870272472692,0.624821192894509,PSMB8/PSMA6/CDKN1A,3
R-HSA-5607761,R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,2/230,58/8183,0.488335428772872,0.739870272472692,0.624821192894509,PSMB8/PSMA6,2
R-HSA-8943724,R-HSA-8943724,Regulation of PTEN gene transcription,2/230,58/8183,0.488335428772872,0.739870272472692,0.624821192894509,EGR1/JUN,2
R-HSA-9006925,R-HSA-9006925,Intracellular signaling by second messengers,8/230,271/8183,0.495167671998926,0.741911287487331,0.626544832137238,RAC1/EGR1/HGF/PSMB8/PSMA6/CDKN1A/JUN/CAMK2B,8
R-HSA-9020702,R-HSA-9020702,Interleukin-1 signaling,3/230,94/8183,0.49524796236242,0.741911287487331,0.626544832137238,PSMB8/RBX1/PSMA6,3
R-HSA-1266695,R-HSA-1266695,Interleukin-7 signaling,1/230,24/8183,0.496014658775314,0.741911287487331,0.626544832137238,HGF,1
R-HSA-399719,R-HSA-399719,Trafficking of AMPA receptors,1/230,24/8183,0.496014658775314,0.741911287487331,0.626544832137238,CAMK2B,1
R-HSA-399721,R-HSA-399721,Glutamate binding, activation of AMPA receptors and synaptic plasticity,1/230,24/8183,0.496014658775314,0.741911287487331,0.626544832137238,CAMK2B,1
R-HSA-9013507,R-HSA-9013507,NOTCH3 Activation and Transmission of Signal to the Nucleus,1/230,24/8183,0.496014658775314,0.741911287487331,0.626544832137238,YBX1,1
R-HSA-1474228,R-HSA-1474228,Degradation of the extracellular matrix,3/230,95/8183,0.502338108150519,0.749774288810647,0.633185144701962,TIMP1/BSG/ELN,3
R-HSA-6790901,R-HSA-6790901,rRNA modification in the nucleus and cytosol,2/230,60/8183,0.506351007159886,0.750291818387071,0.633622198952322,RPS2/RPS14,2
R-HSA-5620912,R-HSA-5620912,Anchoring of the basal body to the plasma membrane,3/230,96/8183,0.509377456799019,0.750291818387071,0.633622198952322,TUBA1A/YWHAG/TUBB4B,3
R-HSA-2173788,R-HSA-2173788,Downregulation of TGF-beta receptor signaling,1/230,25/8183,0.510221869031678,0.750291818387071,0.633622198952322,PPP1R15A,1
R-HSA-418990,R-HSA-418990,Adherens junctions interactions,1/230,25/8183,0.510221869031678,0.750291818387071,0.633622198952322,CDH18,1
R-HSA-429947,R-HSA-429947,Deadenylation of mRNA,1/230,25/8183,0.510221869031678,0.750291818387071,0.633622198952322,EIF4A2,1
R-HSA-525793,R-HSA-525793,Myogenesis,1/230,25/8183,0.510221869031678,0.750291818387071,0.633622198952322,CDC42,1
R-HSA-5674400,R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,1/230,25/8183,0.510221869031678,0.750291818387071,0.633622198952322,CDKN1A,1
R-HSA-4608870,R-HSA-4608870,Asymmetric localization of PCP proteins,2/230,61/8183,0.515203727296582,0.750291818387071,0.633622198952322,PSMB8/PSMA6,2
R-HSA-6796648,R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,2/230,61/8183,0.515203727296582,0.750291818387071,0.633622198952322,FOS/JUN,2
R-HSA-1852241,R-HSA-1852241,Organelle biogenesis and maintenance,8/230,277/8183,0.520238940796156,0.750291818387071,0.633622198952322,TUBB2B/TUBA1A/TUBB2A/TUBB3/ATP5F1E/ATP5ME/YWHAG/TUBB4B,8
R-HSA-6807070,R-HSA-6807070,PTEN Regulation,4/230,134/8183,0.523132483894114,0.750291818387071,0.633622198952322,EGR1/PSMB8/PSMA6/JUN,4
R-HSA-948021,R-HSA-948021,Transport to the Golgi and subsequent modification,5/230,170/8183,0.523254353087481,0.750291818387071,0.633622198952322,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-216083,R-HSA-216083,Integrin cell surface interactions,2/230,62/8183,0.523951338185329,0.750291818387071,0.633622198952322,BSG/CD47,2
R-HSA-70171,R-HSA-70171,Glycolysis,2/230,62/8183,0.523951338185329,0.750291818387071,0.633622198952322,PGAM2/ALDOA,2
R-HSA-74752,R-HSA-74752,Signaling by Insulin receptor,2/230,62/8183,0.523951338185329,0.750291818387071,0.633622198952322,ATP6AP1/ATP6V0E2,2
R-HSA-110373,R-HSA-110373,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,1/230,26/8183,0.524030274293104,0.750291818387071,0.633622198952322,BPHL,1
R-HSA-1222556,R-HSA-1222556,ROS and RNS production in phagocytes,1/230,26/8183,0.524030274293104,0.750291818387071,0.633622198952322,ATP6V0E2,1
R-HSA-1483191,R-HSA-1483191,Synthesis of PC,1/230,26/8183,0.524030274293104,0.750291818387071,0.633622198952322,MFSD2A,1
R-HSA-3928663,R-HSA-3928663,EPHA-mediated growth cone collapse,1/230,26/8183,0.524030274293104,0.750291818387071,0.633622198952322,RHOA,1
R-HSA-8874081,R-HSA-8874081,MET activates PTK2 signaling,1/230,26/8183,0.524030274293104,0.750291818387071,0.633622198952322,HGF,1
R-HSA-174084,R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,2/230,63/8183,0.532592734101164,0.757956717976219,0.640095214402318,PSMB8/PSMA6,2
R-HSA-450294,R-HSA-450294,MAP kinase activation,2/230,63/8183,0.532592734101164,0.757956717976219,0.640095214402318,FOS/JUN,2
R-HSA-69620,R-HSA-69620,Cell Cycle Checkpoints,8/230,280/8183,0.53261823425356,0.757956717976219,0.640095214402318,RPS27/YWHAH/HIST1H4C/MAD1L1/PSMB8/PSMA6/CDKN1A/YWHAG,8
R-HSA-156590,R-HSA-156590,Glutathione conjugation,1/230,27/8183,0.53745102173856,0.758690900165076,0.640715232002849,GGCT,1
R-HSA-442742,R-HSA-442742,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,1/230,27/8183,0.53745102173856,0.758690900165076,0.640715232002849,CAMK2B,1
R-HSA-5218920,R-HSA-5218920,VEGFR2 mediated vascular permeability,1/230,27/8183,0.53745102173856,0.758690900165076,0.640715232002849,RAC1,1
R-HSA-8979227,R-HSA-8979227,Triglyceride metabolism,1/230,27/8183,0.53745102173856,0.758690900165076,0.640715232002849,FABP5,1
R-HSA-1169091,R-HSA-1169091,Activation of NF-kappaB in B cells,2/230,64/8183,0.541126953638288,0.762349195205844,0.643804665862239,PSMB8/PSMA6,2
R-HSA-983705,R-HSA-983705,Signaling by the B Cell Receptor (BCR),3/230,101/8183,0.543771567947386,0.764542824534025,0.645657188047001,PPIA/PSMB8/PSMA6,3
R-HSA-174154,R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,2/230,65/8183,0.549553172535987,0.764818080339695,0.645889641853093,PSMB8/PSMA6,2
R-HSA-422356,R-HSA-422356,Regulation of insulin secretion,2/230,65/8183,0.549553172535987,0.764818080339695,0.645889641853093,GNB2/GNG2,2
R-HSA-418594,R-HSA-418594,G alpha (i) signalling events,7/230,248/8183,0.550170183304463,0.764818080339695,0.645889641853093,NPW/RGS7/GNB2/PSAP/GNG2/RBP1/CAMK2B,7
R-HSA-1500931,R-HSA-1500931,Cell-Cell communication,3/230,102/8183,0.550482606490492,0.764818080339695,0.645889641853093,CLDN18/CDH18/CD47,3
R-HSA-182971,R-HSA-182971,EGFR downregulation,1/230,28/8183,0.550494948295712,0.764818080339695,0.645889641853093,CDC42,1
R-HSA-70268,R-HSA-70268,Pyruvate metabolism,1/230,28/8183,0.550494948295712,0.764818080339695,0.645889641853093,BSG,1
R-HSA-68867,R-HSA-68867,Assembly of the pre-replicative complex,2/230,66/8183,0.557870696790893,0.772013976070862,0.651966583070998,PSMB8/PSMA6,2
R-HSA-8948751,R-HSA-8948751,Regulation of PTEN stability and activity,2/230,66/8183,0.557870696790893,0.772013976070862,0.651966583070998,PSMB8/PSMA6,2
R-HSA-162588,R-HSA-162588,Budding and maturation of HIV virion,1/230,29/8183,0.563172589238936,0.777819902229807,0.656869693580312,PPIA,1
R-HSA-418346,R-HSA-418346,Platelet homeostasis,2/230,67/8183,0.566078956045257,0.78030099235258,0.658964976696647,GNB2/GNG2,2
R-HSA-5576891,R-HSA-5576891,Cardiac conduction,3/230,105/8183,0.570264171357805,0.782538516720897,0.660854568287169,CACNA2D1/CAMK2B/NPPA,3
R-HSA-1474244,R-HSA-1474244,Extracellular matrix organization,6/230,216/8183,0.570351411877727,0.782538516720897,0.660854568287169,TIMP1/BSG/PPIB/MFAP2/ELN/CD47,6
R-HSA-448424,R-HSA-448424,Interleukin-17 signaling,2/230,68/8183,0.574177497241276,0.782538516720897,0.660854568287169,FOS/JUN,2
R-HSA-110314,R-HSA-110314,Recognition of DNA damage by PCNA-containing replication complex,1/230,30/8183,0.575494186550077,0.782538516720897,0.660854568287169,RBX1,1
R-HSA-381042,R-HSA-381042,PERK regulates gene expression,1/230,30/8183,0.575494186550077,0.782538516720897,0.660854568287169,HSPA5,1
R-HSA-8866652,R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,1/230,30/8183,0.575494186550077,0.782538516720897,0.660854568287169,UBE2S,1
R-HSA-975634,R-HSA-975634,Retinoid metabolism and transport,1/230,30/8183,0.575494186550077,0.782538516720897,0.660854568287169,RBP1,1
R-HSA-6794362,R-HSA-6794362,Protein-protein interactions at synapses,2/230,69/8183,0.582165978531836,0.790082399436064,0.667225384864775,SLITRK6/SYT1,2
R-HSA-2173789,R-HSA-2173789,TGF-beta receptor signaling activates SMADs,1/230,31/8183,0.58746969704848,0.791605051330504,0.668511265928583,PPP1R15A,1
R-HSA-2173796,R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,1/230,31/8183,0.58746969704848,0.791605051330504,0.668511265928583,JUNB,1
R-HSA-5362517,R-HSA-5362517,Signaling by Retinoic Acid,1/230,31/8183,0.58746969704848,0.791605051330504,0.668511265928583,FABP5,1
R-HSA-174178,R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,2/230,70/8183,0.590044163438384,0.791605051330504,0.668511265928583,PSMB8/PSMA6,2
R-HSA-174184,R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,2/230,70/8183,0.590044163438384,0.791605051330504,0.668511265928583,PSMB8/PSMA6,2
R-HSA-69017,R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,2/230,70/8183,0.590044163438384,0.791605051330504,0.668511265928583,PSMB8/PSMA6,2
R-HSA-983712,R-HSA-983712,Ion channel transport,4/230,146/8183,0.591373138292094,0.79167948610625,0.668574126171932,ATP6AP1/SGK1/ATP6V0E2/CAMK2B,4
R-HSA-1296071,R-HSA-1296071,Potassium Channels,2/230,71/8183,0.597811915246931,0.79167948610625,0.668574126171932,GNB2/GNG2,2
R-HSA-159236,R-HSA-159236,Transport of Mature mRNA derived from an Intron-Containing Transcript,2/230,71/8183,0.597811915246931,0.79167948610625,0.668574126171932,SRSF9/THOC7,2
R-HSA-179419,R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,2/230,71/8183,0.597811915246931,0.79167948610625,0.668574126171932,PSMB8/PSMA6,2
R-HSA-163841,R-HSA-163841,Gamma carboxylation, hypusine formation and arylsulfatase activation,1/230,32/8183,0.599108800296622,0.79167948610625,0.668574126171932,EEF2,1
R-HSA-1980145,R-HSA-1980145,Signaling by NOTCH2,1/230,32/8183,0.599108800296622,0.79167948610625,0.668574126171932,MDK,1
R-HSA-5673000,R-HSA-5673000,RAF activation,1/230,32/8183,0.599108800296622,0.79167948610625,0.668574126171932,CAMK2B,1
R-HSA-5689901,R-HSA-5689901,Metalloprotease DUBs,1/230,32/8183,0.599108800296622,0.79167948610625,0.668574126171932,HIST1H2AC,1
R-HSA-199992,R-HSA-199992,trans-Golgi Network Vesicle Budding,2/230,72/8183,0.605469191633518,0.796580916406772,0.672713389014628,VAMP8/FTH1,2
R-HSA-6811442,R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,5/230,187/8183,0.608588616376285,0.796580916406772,0.672713389014628,TUBB2B/TUBA1A/TUBB2A/TUBB3/TUBB4B,5
R-HSA-111933,R-HSA-111933,Calmodulin induced events,1/230,33/8183,0.610420906287515,0.796580916406772,0.672713389014628,CAMK2B,1
R-HSA-111997,R-HSA-111997,CaM pathway,1/230,33/8183,0.610420906287515,0.796580916406772,0.672713389014628,CAMK2B,1
R-HSA-165054,R-HSA-165054,Rev-mediated nuclear export of HIV RNA,1/230,33/8183,0.610420906287515,0.796580916406772,0.672713389014628,RANBP1,1
R-HSA-9022692,R-HSA-9022692,Regulation of MECP2 expression and activity,1/230,33/8183,0.610420906287515,0.796580916406772,0.672713389014628,CAMK2B,1
R-HSA-176409,R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,2/230,73/8183,0.613016039510759,0.796580916406772,0.672713389014628,PSMB8/PSMA6,2
R-HSA-446728,R-HSA-446728,Cell junction organization,2/230,73/8183,0.613016039510759,0.796580916406772,0.672713389014628,CLDN18/CDH18,2
R-HSA-8852135,R-HSA-8852135,Protein ubiquitination,2/230,73/8183,0.613016039510759,0.796580916406772,0.672713389014628,HLA-A/UBE2S,2
R-HSA-211000,R-HSA-211000,Gene Silencing by RNA,3/230,113/8183,0.620321341232142,0.800100475334587,0.675685660086407,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-176814,R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,2/230,74/8183,0.620452590087369,0.800100475334587,0.675685660086407,PSMB8/PSMA6,2
R-HSA-111996,R-HSA-111996,Ca-dependent events,1/230,34/8183,0.621415162919892,0.800100475334587,0.675685660086407,CAMK2B,1
R-HSA-6788656,R-HSA-6788656,Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism,1/230,34/8183,0.621415162919892,0.800100475334587,0.675685660086407,PCBD1,1
R-HSA-6806667,R-HSA-6806667,Metabolism of fat-soluble vitamins,1/230,34/8183,0.621415162919892,0.800100475334587,0.675685660086407,RBP1,1
R-HSA-2871837,R-HSA-2871837,FCERI mediated NF-kB activation,2/230,75/8183,0.627779054132858,0.805141820900114,0.679943081511813,PSMB8/PSMA6,2
R-HSA-3214815,R-HSA-3214815,HDACs deacetylate histones,2/230,75/8183,0.627779054132858,0.805141820900114,0.679943081511813,HIST1H2AC/HIST1H4C,2
R-HSA-176033,R-HSA-176033,Interactions of Vpr with host cellular proteins,1/230,35/8183,0.632100463266981,0.805141820900114,0.679943081511813,SLC25A6,1
R-HSA-177243,R-HSA-177243,Interactions of Rev with host cellular proteins,1/230,35/8183,0.632100463266981,0.805141820900114,0.679943081511813,RANBP1,1
R-HSA-432720,R-HSA-432720,Lysosome Vesicle Biogenesis,1/230,35/8183,0.632100463266981,0.805141820900114,0.679943081511813,VAMP8,1
R-HSA-446652,R-HSA-446652,Interleukin-1 family signaling,3/230,115/8183,0.632202397065239,0.805141820900114,0.679943081511813,PSMB8/RBX1/PSMA6,3
R-HSA-111465,R-HSA-111465,Apoptotic cleavage of cellular proteins,1/230,36/8183,0.64248545264457,0.812351210807792,0.686031418575421,DSP,1
R-HSA-5689896,R-HSA-5689896,Ovarian tumor domain proteases,1/230,36/8183,0.64248545264457,0.812351210807792,0.686031418575421,RHOA,1
R-HSA-6804757,R-HSA-6804757,Regulation of TP53 Degradation,1/230,36/8183,0.64248545264457,0.812351210807792,0.686031418575421,SGK1,1
R-HSA-6806003,R-HSA-6806003,Regulation of TP53 Expression and Degradation,1/230,36/8183,0.64248545264457,0.812351210807792,0.686031418575421,SGK1,1
R-HSA-69239,R-HSA-69239,Synthesis of DNA,3/230,117/8183,0.643825067445686,0.812583523185489,0.686227606613185,PSMB8/RBX1/PSMA6,3
R-HSA-176408,R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,2/230,78/8183,0.649101134223417,0.81541748019951,0.688620886175823,PSMB8/PSMA6,2
R-HSA-6811558,R-HSA-6811558,PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling,2/230,78/8183,0.649101134223417,0.81541748019951,0.688620886175823,RAC1/HGF,2
R-HSA-5663202,R-HSA-5663202,Diseases of signal transduction,9/230,348/8183,0.649550197598471,0.81541748019951,0.688620886175823,RBP1/RAC1/OS9/HGF/PSMB8/RBX1/PSMA6/CDKN1A/CAMK2B,9
R-HSA-3769402,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,1/230,37/8183,0.652578535483866,0.817758842148232,0.690598168707948,SOX4,1
R-HSA-69242,R-HSA-69242,S Phase,4/230,159/8183,0.658462645399152,0.823196190809867,0.695190015148259,PSMB8/RBX1/PSMA6/CDKN1A,4
R-HSA-68875,R-HSA-68875,Mitotic Prophase,3/230,120/8183,0.660771649817864,0.823196190809867,0.695190015148259,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-1660662,R-HSA-1660662,Glycosphingolipid metabolism,1/230,38/8183,0.662387882014521,0.823196190809867,0.695190015148259,PSAP,1
R-HSA-5696394,R-HSA-5696394,DNA Damage Recognition in GG-NER,1/230,38/8183,0.662387882014521,0.823196190809867,0.695190015148259,RBX1,1
R-HSA-72202,R-HSA-72202,Transport of Mature Transcript to Cytoplasm,2/230,80/8183,0.662772466569537,0.823196190809867,0.695190015148259,SRSF9/THOC7,2
R-HSA-8878171,R-HSA-8878171,Transcriptional regulation by RUNX1,5/230,200/8183,0.667574993777884,0.825650985059056,0.697263091372775,HIST1H2AC/HIST1H4C/PSMB8/H2AFV/PSMA6,5
R-HSA-168142,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,2/230,81/8183,0.669446744642478,0.825650985059056,0.697263091372775,FOS/JUN,2
R-HSA-168176,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,2/230,81/8183,0.669446744642478,0.825650985059056,0.697263091372775,FOS/JUN,2
R-HSA-975871,R-HSA-975871,MyD88 cascade initiated on plasma membrane,2/230,81/8183,0.669446744642478,0.825650985059056,0.697263091372775,FOS/JUN,2
R-HSA-112310,R-HSA-112310,Neurotransmitter release cycle,1/230,39/8183,0.671921434763037,0.825805539577648,0.697393612819935,SYT1,1
R-HSA-1489509,R-HSA-1489509,DAG and IP3 signaling,1/230,39/8183,0.671921434763037,0.825805539577648,0.697393612819935,CAMK2B,1
R-HSA-5668541,R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,2/230,82/8183,0.676014281221799,0.827940835712413,0.6991968725639,PSMB8/PSMA6,2
R-HSA-69002,R-HSA-69002,DNA Replication Pre-Initiation,2/230,82/8183,0.676014281221799,0.827940835712413,0.6991968725639,PSMB8/PSMA6,2
R-HSA-168253,R-HSA-168253,Host Interactions with Influenza Factors,1/230,40/8183,0.681186914871644,0.832825045486549,0.703321592654659,SLC25A6,1
R-HSA-69306,R-HSA-69306,DNA Replication,3/230,124/8183,0.682454213893318,0.832925889526046,0.703406755547938,PSMB8/RBX1/PSMA6,3
R-HSA-174143,R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,2/230,84/8183,0.688831971029858,0.834457388115943,0.704700107655,PSMB8/PSMA6,2
R-HSA-453276,R-HSA-453276,Regulation of mitotic cell cycle,2/230,84/8183,0.688831971029858,0.834457388115943,0.704700107655,PSMB8/PSMA6,2
R-HSA-975138,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,2/230,84/8183,0.688831971029858,0.834457388115943,0.704700107655,FOS/JUN,2
R-HSA-1433557,R-HSA-1433557,Signaling by SCF-KIT,1/230,41/8183,0.690191828242579,0.834457388115943,0.704700107655,RAC1,1
R-HSA-5696400,R-HSA-5696400,Dual Incision in GG-NER,1/230,41/8183,0.690191828242579,0.834457388115943,0.704700107655,RBX1,1
R-HSA-168181,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,2/230,85/8183,0.695083654294312,0.834457388115943,0.704700107655,FOS/JUN,2
R-HSA-199418,R-HSA-199418,Negative regulation of the PI3K/AKT network,2/230,85/8183,0.695083654294312,0.834457388115943,0.704700107655,RAC1/HGF,2
R-HSA-975155,R-HSA-975155,MyD88 dependent cascade initiated on endosome,2/230,85/8183,0.695083654294312,0.834457388115943,0.704700107655,FOS/JUN,2
R-HSA-3214842,R-HSA-3214842,HDMs demethylate histones,1/230,42/8183,0.698943471512563,0.834457388115943,0.704700107655,HIST1H4C,1
R-HSA-6782315,R-HSA-6782315,tRNA modification in the nucleus and cytosol,1/230,42/8183,0.698943471512563,0.834457388115943,0.704700107655,TRIT1,1
R-HSA-202424,R-HSA-202424,Downstream TCR signaling,2/230,86/8183,0.701231650154189,0.834457388115943,0.704700107655,PSMB8/PSMA6,2
R-HSA-212165,R-HSA-212165,Epigenetic regulation of gene expression,3/230,128/8183,0.703095295295458,0.834457388115943,0.704700107655,HIST1H2AC/HIST1H4C/H2AFV,3
R-HSA-1592230,R-HSA-1592230,Mitochondrial biogenesis,2/230,87/8183,0.707276819868809,0.834457388115943,0.704700107655,ATP5F1E/ATP5ME,2
R-HSA-5368286,R-HSA-5368286,Mitochondrial translation initiation,2/230,87/8183,0.707276819868809,0.834457388115943,0.704700107655,MRPS24/MRPL33,2
R-HSA-5389840,R-HSA-5389840,Mitochondrial translation elongation,2/230,87/8183,0.707276819868809,0.834457388115943,0.704700107655,MRPS24/MRPL33,2
R-HSA-5419276,R-HSA-5419276,Mitochondrial translation termination,2/230,87/8183,0.707276819868809,0.834457388115943,0.704700107655,MRPS24/MRPL33,2
R-HSA-2173793,R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,1/230,43/8183,0.707448937862165,0.834457388115943,0.704700107655,JUNB,1
R-HSA-5696395,R-HSA-5696395,Formation of Incision Complex in GG-NER,1/230,43/8183,0.707448937862165,0.834457388115943,0.704700107655,RBX1,1
R-HSA-6802946,R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,1/230,43/8183,0.707448937862165,0.834457388115943,0.704700107655,CAMK2B,1
R-HSA-6802955,R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,1/230,43/8183,0.707448937862165,0.834457388115943,0.704700107655,CAMK2B,1
R-HSA-69206,R-HSA-69206,G1/S Transition,3/230,130/8183,0.713027734925739,0.836679055112235,0.706576307678821,PSMB8/PSMA6/CDKN1A,3
R-HSA-5578775,R-HSA-5578775,Ion homeostasis,1/230,44/8183,0.715715122664585,0.836679055112235,0.706576307678821,CAMK2B,1
R-HSA-69231,R-HSA-69231,Cyclin D associated events in G1,1/230,44/8183,0.715715122664585,0.836679055112235,0.706576307678821,CDKN1A,1
R-HSA-69236,R-HSA-69236,G1 Phase,1/230,44/8183,0.715715122664585,0.836679055112235,0.706576307678821,CDKN1A,1
R-HSA-166058,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,2/230,89/8183,0.719062291185726,0.836679055112235,0.706576307678821,FOS/JUN,2
R-HSA-168138,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,2/230,89/8183,0.719062291185726,0.836679055112235,0.706576307678821,FOS/JUN,2
R-HSA-168188,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,2/230,89/8183,0.719062291185726,0.836679055112235,0.706576307678821,FOS/JUN,2
R-HSA-1483249,R-HSA-1483249,Inositol phosphate metabolism,1/230,45/8183,0.723748728978278,0.836679055112235,0.706576307678821,NUDT3,1
R-HSA-166520,R-HSA-166520,Signaling by NTRKs,2/230,90/8183,0.724804473063089,0.836679055112235,0.706576307678821,RHOA/RAC1,2
R-HSA-168164,R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,2/230,90/8183,0.724804473063089,0.836679055112235,0.706576307678821,FOS/JUN,2
R-HSA-168179,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,2/230,90/8183,0.724804473063089,0.836679055112235,0.706576307678821,FOS/JUN,2
R-HSA-181438,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,2/230,90/8183,0.724804473063089,0.836679055112235,0.706576307678821,FOS/JUN,2
R-HSA-193704,R-HSA-193704,p75 NTR receptor-mediated signalling,2/230,90/8183,0.724804473063089,0.836679055112235,0.706576307678821,RHOA/RAC1,2
R-HSA-5688426,R-HSA-5688426,Deubiquitination,6/230,255/8183,0.72805901780764,0.838650534324668,0.708241223866306,UCHL1/RHOA/HIST1H2AC/PSMB8/SNX3/PSMA6,6
R-HSA-425407,R-HSA-425407,SLC-mediated transmembrane transport,4/230,175/8183,0.730330381557884,0.838650534324668,0.708241223866306,APOD/BSG/SLC25A6/LCN15,4
R-HSA-177929,R-HSA-177929,Signaling by EGFR,1/230,46/8183,0.731556272887715,0.838650534324668,0.708241223866306,CDC42,1
R-HSA-9012852,R-HSA-9012852,Signaling by NOTCH3,1/230,46/8183,0.731556272887715,0.838650534324668,0.708241223866306,YBX1,1
R-HSA-163685,R-HSA-163685,Integration of energy metabolism,2/230,92/8183,0.735992630512696,0.838650534324668,0.708241223866306,GNB2/GNG2,2
R-HSA-1227986,R-HSA-1227986,Signaling by ERBB2,1/230,47/8183,0.739144088696468,0.838650534324668,0.708241223866306,RHOA,1
R-HSA-2122947,R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,1/230,47/8183,0.739144088696468,0.838650534324668,0.708241223866306,RBX1,1
R-HSA-936837,R-HSA-936837,Ion transport by P-type ATPases,1/230,47/8183,0.739144088696468,0.838650534324668,0.708241223866306,CAMK2B,1
R-HSA-5368287,R-HSA-5368287,Mitochondrial translation,2/230,93/8183,0.741440637509577,0.838650534324668,0.708241223866306,MRPS24/MRPL33,2
R-HSA-112043,R-HSA-112043,PLC beta mediated events,1/230,48/8183,0.746518333976681,0.838650534324668,0.708241223866306,CAMK2B,1
R-HSA-1650814,R-HSA-1650814,Collagen biosynthesis and modifying enzymes,1/230,48/8183,0.746518333976681,0.838650534324668,0.708241223866306,PPIB,1
R-HSA-3928665,R-HSA-3928665,EPH-ephrin mediated repulsion of cells,1/230,48/8183,0.746518333976681,0.838650534324668,0.708241223866306,RAC1,1
R-HSA-6791312,R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,1/230,48/8183,0.746518333976681,0.838650534324668,0.708241223866306,CDKN1A,1
R-HSA-73893,R-HSA-73893,DNA Damage Bypass,1/230,48/8183,0.746518333976681,0.838650534324668,0.708241223866306,RBX1,1
R-HSA-166166,R-HSA-166166,MyD88-independent TLR4 cascade ,2/230,94/8183,0.746792652186688,0.838650534324668,0.708241223866306,FOS/JUN,2
R-HSA-8856825,R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,2/230,94/8183,0.746792652186688,0.838650534324668,0.708241223866306,VAMP8/SYT1,2
R-HSA-937061,R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,2/230,94/8183,0.746792652186688,0.838650534324668,0.708241223866306,FOS/JUN,2
R-HSA-5689880,R-HSA-5689880,Ub-specific processing proteases,4/230,180/8183,0.750331895058096,0.839192010517637,0.708698501058542,HIST1H2AC/PSMB8/SNX3/PSMA6,4
R-HSA-141424,R-HSA-141424,Amplification of signal from the kinetochores,2/230,95/8183,0.752049739155208,0.839192010517637,0.708698501058542,RPS27/MAD1L1,2
R-HSA-141444,R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,2/230,95/8183,0.752049739155208,0.839192010517637,0.708698501058542,RPS27/MAD1L1,2
R-HSA-5607764,R-HSA-5607764,CLEC7A (Dectin-1) signaling,2/230,95/8183,0.752049739155208,0.839192010517637,0.708698501058542,PSMB8/PSMA6,2
R-HSA-112040,R-HSA-112040,G-protein mediated events,1/230,49/8183,0.753684994478877,0.839683916194374,0.709113915899719,CAMK2B,1
R-HSA-6794361,R-HSA-6794361,Neurexins and neuroligins,1/230,50/8183,0.760649888905955,0.846102645412795,0.714534539212123,SYT1,1
R-HSA-5619115,R-HSA-5619115,Disorders of transmembrane transporters,3/230,142/8183,0.767315175173567,0.852168354102714,0.719657036331408,OS9/PSMB8/PSMA6,3
R-HSA-193648,R-HSA-193648,NRAGE signals death through JNK,1/230,53/8183,0.780389753636022,0.862600623908999,0.728467098726773,RAC1,1
R-HSA-6781823,R-HSA-6781823,Formation of TC-NER Pre-Incision Complex,1/230,53/8183,0.780389753636022,0.862600623908999,0.728467098726773,RBX1,1
R-HSA-8866654,R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,1/230,53/8183,0.780389753636022,0.862600623908999,0.728467098726773,HLA-A,1
R-HSA-425366,R-HSA-425366,Transport of bile salts and organic acids, metal ions and amine compounds,1/230,54/8183,0.786602589634019,0.868103014933619,0.733113873508364,BSG,1
R-HSA-453279,R-HSA-453279,Mitotic G1-G1/S phases,3/230,148/8183,0.791176509891023,0.871782267168322,0.736221005739213,PSMB8/PSMA6/CDKN1A,3
R-HSA-6802949,R-HSA-6802949,Signaling by RAS mutants,1/230,55/8183,0.792640405402769,0.872028489824956,0.7364289410216,CAMK2B,1
R-HSA-202403,R-HSA-202403,TCR signaling,2/230,104/8183,0.79527414216001,0.873558940528886,0.737721408187904,PSMB8/PSMA6,2
R-HSA-73894,R-HSA-73894,DNA Repair,7/230,318/8183,0.796780965740767,0.873848703456723,0.737966113273327,TERF2IP/HIST1H2AC/HIST1H4C/BPHL/H2AFV/RBX1/NTHL1,7
R-HSA-397014,R-HSA-397014,Muscle contraction,3/230,150/8183,0.798667288586551,0.873984988010009,0.738081205716321,CACNA2D1/CAMK2B/NPPA,3
R-HSA-9006934,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,9/230,400/8183,0.799391674666338,0.873984988010009,0.738081205716321,SPINT2/RHOA/CDC42/RAC1/BRK1/ATP6AP1/HGF/ATP6V0E2/VEGFA,9
R-HSA-8873719,R-HSA-8873719,RAB geranylgeranylation,1/230,57/8183,0.804210477218325,0.877127515791438,0.74073507360391,RAB13,1
R-HSA-2644602,R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,1/230,58/8183,0.809752144734912,0.877127515791438,0.74073507360391,RBX1,1
R-HSA-2644603,R-HSA-2644603,Signaling by NOTCH1 in Cancer,1/230,58/8183,0.809752144734912,0.877127515791438,0.74073507360391,RBX1,1
R-HSA-2644606,R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,1/230,58/8183,0.809752144734912,0.877127515791438,0.74073507360391,RBX1,1
R-HSA-2894858,R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,1/230,58/8183,0.809752144734912,0.877127515791438,0.74073507360391,RBX1,1
R-HSA-2894862,R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,1/230,58/8183,0.809752144734912,0.877127515791438,0.74073507360391,RBX1,1
R-HSA-5693571,R-HSA-5693571,Nonhomologous End-Joining (NHEJ),1/230,59/8183,0.815137622483955,0.881602690163416,0.74451436288413,HIST1H4C,1
R-HSA-163125,R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,1/230,60/8183,0.820371293930125,0.885900183767862,0.748143600576588,NRN1,1
R-HSA-69618,R-HSA-69618,Mitotic Spindle Checkpoint,2/230,111/8183,0.824166296295617,0.888633291864753,0.750451713126781,RPS27/MAD1L1,2
R-HSA-211945,R-HSA-211945,Phase I - Functionalization of compounds,1/230,61/8183,0.825457420040684,0.888662429232161,0.750476319663007,BPHL,1
R-HSA-3214841,R-HSA-3214841,PKMTs methylate histone lysines,1/230,62/8183,0.830400142694051,0.892616667146663,0.753815677578376,HIST1H4C,1
R-HSA-6802952,R-HSA-6802952,Signaling by BRAF and RAF fusions,1/230,63/8183,0.835203487993936,0.896409239785858,0.757018509005352,CAMK2B,1
R-HSA-166016,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,2/230,115/8183,0.838988641622815,0.898675148786342,0.758932071446427,FOS/JUN,2
R-HSA-6782210,R-HSA-6782210,Gap-filling DNA repair synthesis and ligation in TC-NER,1/230,64/8183,0.839871369491645,0.898675148786342,0.758932071446427,RBX1,1
R-HSA-2187338,R-HSA-2187338,Visual phototransduction,1/230,65/8183,0.844407591319077,0.899422025298956,0.759562809416203,RBP1,1
R-HSA-5693565,R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,1/230,65/8183,0.844407591319077,0.899422025298956,0.759562809416203,HIST1H4C,1
R-HSA-6782135,R-HSA-6782135,Dual incision in TC-NER,1/230,65/8183,0.844407591319077,0.899422025298956,0.759562809416203,RBX1,1
R-HSA-5693606,R-HSA-5693606,DNA Double Strand Break Response,1/230,66/8183,0.848815851234895,0.902472632464859,0.762139050251075,HIST1H4C,1
R-HSA-1474290,R-HSA-1474290,Collagen formation,1/230,67/8183,0.853099743586253,0.902472632464859,0.762139050251075,PPIB,1
R-HSA-156580,R-HSA-156580,Phase II - Conjugation of compounds,1/230,67/8183,0.853099743586253,0.902472632464859,0.762139050251075,GGCT,1
R-HSA-4551638,R-HSA-4551638,SUMOylation of chromatin organization proteins,1/230,67/8183,0.853099743586253,0.902472632464859,0.762139050251075,HIST1H4C,1
R-HSA-3108232,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,3/230,167/8183,0.853690328007299,0.902472632464859,0.762139050251075,PARK7/HIST1H4C/DDX17,3
R-HSA-3700989,R-HSA-3700989,Transcriptional Regulation by TP53,7/230,344/8183,0.856858286480141,0.904461524617927,0.763818671684526,FOS/COX4I1/YWHAH/SGK1/CDKN1A/YWHAG/JUN,7
R-HSA-3214847,R-HSA-3214847,HATs acetylate histones,2/230,121/8183,0.859115044591444,0.905484072485435,0.764682214392132,HIST1H2AC/HIST1H4C,2
R-HSA-8957322,R-HSA-8957322,Metabolism of steroids,2/230,122/8183,0.862237905491718,0.9074150412585,0.766312919472627,TSPO/AKR1B1,2
R-HSA-1169408,R-HSA-1169408,ISG15 antiviral mechanism,1/230,70/8183,0.865239667467821,0.907855949596833,0.766685267009978,EIF4A2,1
R-HSA-204998,R-HSA-204998,Cell death signalling via NRAGE, NRIF and NADE,1/230,70/8183,0.865239667467821,0.907855949596833,0.766685267009978,RAC1,1
R-HSA-5621481,R-HSA-5621481,C-type lectin receptors (CLRs),2/230,124/8183,0.868294948342404,0.909703947369166,0.768245902996495,PSMB8/PSMA6,2
R-HSA-2990846,R-HSA-2990846,SUMOylation,3/230,173/8183,0.869733066825795,0.909854681515675,0.768373198135571,PARK7/HIST1H4C/DDX17,3
R-HSA-187037,R-HSA-187037,Signaling by NTRK1 (TRKA),1/230,73/8183,0.876380341590705,0.91408810109535,0.771948325249348,RHOA,1
R-HSA-1980143,R-HSA-1980143,Signaling by NOTCH1,1/230,73/8183,0.876380341590705,0.91408810109535,0.771948325249348,RBX1,1
R-HSA-73887,R-HSA-73887,Death Receptor Signalling,2/230,131/8183,0.887623563423714,0.921794070883199,0.778456024523657,RHOA/RAC1,2
R-HSA-1169410,R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,1/230,77/8183,0.889820800821778,0.921794070883199,0.778456024523657,EIF4A2,1
R-HSA-162599,R-HSA-162599,Late Phase of HIV Life Cycle,2/230,132/8183,0.89016079433598,0.921794070883199,0.778456024523657,PPIA/RANBP1,2
R-HSA-211859,R-HSA-211859,Biological oxidations,2/230,132/8183,0.89016079433598,0.921794070883199,0.778456024523657,GGCT/BPHL,2
R-HSA-428157,R-HSA-428157,Sphingolipid metabolism,1/230,78/8183,0.89294703025812,0.921794070883199,0.778456024523657,PSAP,1
R-HSA-6781827,R-HSA-6781827,Transcription-Coupled Nucleotide Excision Repair (TC-NER),1/230,78/8183,0.89294703025812,0.921794070883199,0.778456024523657,RBX1,1
R-HSA-6802957,R-HSA-6802957,Oncogenic MAPK signaling,1/230,78/8183,0.89294703025812,0.921794070883199,0.778456024523657,CAMK2B,1
R-HSA-8856828,R-HSA-8856828,Clathrin-mediated endocytosis,2/230,134/8183,0.895077116249266,0.922638141822923,0.779168843285362,VAMP8/SYT1,2
R-HSA-2672351,R-HSA-2672351,Stimuli-sensing channels,1/230,82/8183,0.904593162568383,0.931081981384441,0.786299674329302,SGK1,1
R-HSA-5696399,R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),1/230,84/8183,0.909934079146928,0.935210025789899,0.789785812001951,RBX1,1
R-HSA-8876198,R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs,1/230,85/8183,0.912491822299936,0.935629022401906,0.790139655064273,RAB13,1
R-HSA-162587,R-HSA-162587,HIV Life Cycle,2/230,143/8183,0.91477545546131,0.935629022401906,0.790139655064273,PPIA/RANBP1,2
R-HSA-8978868,R-HSA-8978868,Fatty acid metabolism,2/230,143/8183,0.91477545546131,0.935629022401906,0.790139655064273,PON3/PON2,2
R-HSA-983168,R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,5/230,290/8183,0.915665387500016,0.935629022401906,0.790139655064273,MYLIP/PSMB8/RBX1/PSMA6/UBE2S,5
R-HSA-5693607,R-HSA-5693607,Processing of DNA double-strand break ends,1/230,88/8183,0.919739165242578,0.938427624333139,0.792503077223763,HIST1H4C,1
R-HSA-3247509,R-HSA-3247509,Chromatin modifying enzymes,4/230,249/8183,0.924234025751395,0.940284399570522,0.794071125788387,RPS2/HIST1H2AC/HIST1H4C/H2AFV,4
R-HSA-4839726,R-HSA-4839726,Chromatin organization,4/230,249/8183,0.924234025751395,0.940284399570522,0.794071125788387,RPS2/HIST1H2AC/HIST1H4C/H2AFV,4
R-HSA-71387,R-HSA-71387,Metabolism of carbohydrates,4/230,253/8183,0.929735707477762,0.94451474329027,0.797643655335348,PGAM2/MDH2/AKR1B1/ALDOA,4
R-HSA-196854,R-HSA-196854,Metabolism of vitamins and cofactors,2/230,155/8183,0.935695429528964,0.949197528079165,0.801598271822489,CYB5A/RBP1,2
R-HSA-196849,R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,1/230,103/8183,0.947932485635911,0.958398301297085,0.809368334104299,CYB5A,1
R-HSA-1483206,R-HSA-1483206,Glycerophospholipid biosynthesis,1/230,104/8183,0.949414605475483,0.958398301297085,0.809368334104299,MFSD2A,1
R-HSA-72306,R-HSA-72306,tRNA processing,1/230,104/8183,0.949414605475483,0.958398301297085,0.809368334104299,TRIT1,1
R-HSA-8951664,R-HSA-8951664,Neddylation,3/230,220/8183,0.950218514941775,0.958398301297085,0.809368334104299,PSMB8/RBX1/PSMA6,3
R-HSA-5696398,R-HSA-5696398,Nucleotide Excision Repair,1/230,110/8183,0.957465451412654,0.964324086451427,0.814372665656367,RBX1,1
R-HSA-5693567,R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),1/230,122/8183,0.969938907717907,0.975489344958067,0.823801737750019,HIST1H4C,1
R-HSA-5693538,R-HSA-5693538,Homology Directed Repair,1/230,128/8183,0.974733165988784,0.978910593843022,0.826690985891239,HIST1H4C,1
R-HSA-5633007,R-HSA-5633007,Regulation of TP53 Activity,1/230,153/8183,0.987766676603501,0.989865530015974,0.835942440561517,SGK1,1
R-HSA-5693532,R-HSA-5693532,DNA Double-Strand Break Repair,1/230,155/8183,0.98845747094056,0.989865530015974,0.835942440561517,HIST1H4C,1
R-HSA-1483257,R-HSA-1483257,Phospholipid metabolism,1/230,177/8183,0.993915837558908,0.993915837558908,0.839362929375195,MFSD2A,1
